Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.
- Authors
- Sullivan, Patrick F; Kendler, Kenneth S; Neale, Michael C
- Year
- 2003
- Journal
- Archives of general psychiatry
- PMID
- 14662550
- DOI
- 10.1001/archpsyc.60.12.1187
CONTEXT: There are many published twin studies of schizophrenia. Although these studies have been reviewed previously, to our knowledge, no review has provided quantitative summary estimates of the impact of genes and environment on liability to schizophrenia that also accounted for the different ascertainment strategies used. OBJECTIVE: To calculate meta-analytic estimates of heritability in liability and shared and individual-specific environmental effects from the pooled twin data. DATA SOURCES: We used a structured literature search to identify all published twin studies of schizophrenia, including MEDLINE, dissertation, and books-in-print searches. STUDY SELECTION: Of the 14 identified studies, 12 met the minimal inclusion criteria of systematic ascertainment. DATA SYNTHESIS: By using a multigroup twin model, we found evidence for substantial additive genetic effects-the point estimate of heritability in liability to schizophrenia was 81% (95% confidence interval, 73%-90%). Notably, there was consistent evidence across these studies for common or shared environmental influences on liability to schizophrenia-joint estimate, 11% (95% confidence interval, 3%-19%). CONCLUSIONS: Despite evidence of heterogeneity across studies, these meta-analytic results from 12 published twin studies of schizophrenia are consistent with a view of schizophrenia as a complex trait that results from genetic and environmental etiological influences. These results are broadly informative in that they provide no information about the specific identity of these etiological influences, but they do provide a component of a unifying empirical basis supporting the rationality of searches for underlying genetic and common environmental etiological factors.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A causal coding variant regulating alternative splicing of <i>DOC2A</i> at 16p.11.2 GWAS locus influences susceptibility to schizophrenia. | Zhou D et al. | โ | 2026 | โ |
| Assessment of Social Functioning in Patients With Schizophrenia and Their First-Degree Relatives. | Shimada T et al. | โ | 2026 | โ |
| Association between the Korea-Polyenvironmental Risk Score and Clinical Outcomes in Schizophrenia Spectrum Disorders. | Setiani A et al. | โ | 2026 | โ |
| Characterization of the expression and function of schizophrenia risk gene Dtnbp1 in the suprachiasmatic nucleus. | Maloney GE et al. | โ | 2026 | โ |
| Concordance of positive, negative and disorganised psychotic syndromes in five twin samples. | Cardno AG et al. | โ | 2026 | โ |
| Deciphering the shared genetic architecture between female reproductive disorders and psychiatric disorders. | Li N et al. | โ | 2026 | โ |
| Dynamic Fusion of Genomics and Functional Network Connectivity in UK Biobank Reveals Schizophrenia-Related SNP Manifolds. | Chen J et al. | โ | 2026 | โ |
| Dysregulation of the BRD2-FGF17 Signal Pathway Induces Abnormal Forebrain Development Associated with Schizophrenia. | Yu X et al. | โ | 2026 | โ |
| Functional variants at 1p36.23 confer risk of schizophrenia through modulating RERE. | Liu Y et al. | โ | 2026 | โ |
| Genetic architecture of postpartum psychosis: from common to rare genetic variation. | Jung S et al. | โ | 2026 | โ |
| Global lifetime prevalence of schizophrenia: A systematic review and meta-analysis. | Zhang S et al. | โ | 2026 | โ |
| Intergenerational transmission of the structure of the auditory cortex and reading skills. | Kepinska O et al. | โ | 2026 | โ |
| Molecular regulatory mechanisms of schizophrenia-associated functional non-coding variants. | Dai SS et al. | โ | 2026 | โ |
| Neuropharmacological targets for schizophrenia treatment: An update. | Lima CAC et al. | โ | 2026 | โ |
| Polygenic risk for schizophrenia predicting test-measured and self-reported cognitive performance in individuals without psychosis. | Rosenqvist E et al. | โ | 2026 | โ |
| Polygenic scores for psychiatric traits mediate the impact of multigenerational history for depression on offspring psychopathology. | Lee E et al. | โ | 2026 | โ |
| Relevance of polymorphisms in TLR2/4 genes and their association with plasma cytokines for schizophrenia. | Patlola SR et al. | โ | 2026 | โ |
| Schizophrenia: from mechanism to therapy. | Lu Z et al. | โ | 2026 | โ |
| Schizophrenia-Related Synaptic Dysfunction and Abnormal Sensorimotor Gating in Akap11-Deficient Mice. | Zhang YQ et al. | โ | 2026 | โ |
| The relationship between schizophrenia polygenic scores, blood-based proteins and psychosis diagnosis in the UK Biobank. | Kendall KM et al. | โ | 2026 | โ |
| Absolute and relative risks of mental disorders in families: a Danish register-based study. | Pedersen CB et al. | โ | 2025 | โ |
| Analyses of GWAS and Sub-Threshold Loci Lead to the Discovery of Dendrite Development and Morphology Dysfunction Underlying Schizophrenia Genetic Risk. | Chen R et al. | โ | 2025 | โ |
| Application of Genetic Testing for Anorexia Nervosa: An Ethical Analysis. | Ramsay S et al. | โ | 2025 | โ |
| Assessing the mental health impact of China's housing boom through national and city-level data analysis. | Xiao Y et al. | โ | 2025 | โ |
| Associations of polygenic risk score, environmental factors, and their interactions with the risk of schizophrenia spectrum disorders. | Rami FZ et al. | โ | 2025 | โ |
| Associations of polygenic risk scores differentiating attention-deficit hyperactivity disorder from autism spectrum disorder with cognitive and cortical alterations in Schizophrenia patients. | Kuramitsu A et al. | โ | 2025 | โ |
| A systematic review of miRNA expression in schizophrenia spectrum disorders across the blood and the brain. | Kotas M et al. | โ | 2025 | โ |
| Atad1 Is a Potential Candidate Gene for Prepulse Inhibition. | Bajpai AK et al. | โ | 2025 | โ |
| Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnershipยฎ Schizophrenia Program: design considerations. | Perkins DO et al. | โ | 2025 | โ |
| CD73 polymorphisms are associated with schizophrenia. | Peng HX et al. | โ | 2025 | โ |
| Cognitive predictors and genetic moderators of employment outcomes in people with schizophrenia. | Blackman RK et al. | โ | 2025 | โ |
| Complement Cascades and Brain Disorders. | Jovฤevska I et al. | โ | 2025 | โ |
| Disrupted default mode network connectivity and its role in negative symptoms of schizophrenia. | Cao C et al. | โ | 2025 | โ |
| Eco-Anxiety and Mental Health: Correlates of Climate Change Distress. | Mosca A et al. | โ | 2025 | โ |
| Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophrenia. | Sotero-Moreno A et al. | โ | 2025 | โ |
| Expression study of Wnt/ฮฒ-catenin signaling pathway associated lncRNAs in schizophrenia. | Manafzadeh F et al. | โ | 2025 | โ |
| FoxP2 and Schizophrenia: a systematic review. | Salmรณn-Gรณmez G et al. | โ | 2025 | โ |
| G6PD deficiency in brain induces schizophrenia-like behaviors and synaptic dysfunction. | Wang YB et al. | โ | 2025 | โ |
| Gene-level analysis reveals the genetic aetiology and therapeutic targets of schizophrenia. | Dang X et al. | โ | 2025 | โ |
| Genetic overlap between household income and psychiatric disorders. | Zhang J et al. | โ | 2025 | โ |
| Genetic risk for schizophrenia and brain activation during the Penn Conditional Exclusion Test: A multiplex extended pedigree study. | Rupert PE et al. | โ | 2025 | โ |
| Genomics of schizophrenia, bipolar disorder and major depressive disorder. | Owen MJ et al. | โ | 2025 | โ |
| Human endogenous retroviruses in schizophrenia: clinical evidence, molecular mechanisms, and implications. | Zhang M et al. | โ | 2025 | โ |
| Identification of Bipolar Disorder and Schizophrenia Based on Brain CT and Deep Learning Methods. | Li M et al. | โ | 2025 | โ |
| Identification of genetic architecture shared between schizophrenia and Alzheimer's disease. | Liu H et al. | โ | 2025 | โ |
| Impact of common variants on brain gene expression from RNA to protein to schizophrenia risk. | Liang Q et al. | โ | 2025 | โ |
| Impact of neuroinflammation on brain glutamate and dopamine signalling in schizophrenia: an update. | Nayak U et al. | โ | 2025 | โ |
| Impact of schizophrenia-associated risk genes on brain functional networks and executive deficits: a study of individuals with schizophrenia and genetic high risk. | Sun T et al. | โ | 2025 | โ |
| Initiation of Psychotropic Drugs in Spouses of Patients With Early-Onset Alzheimer's Disease: A Matched Cohort Study. | Fukasawa T et al. | โ | 2025 | โ |
| Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes. | Han S et al. | โ | 2025 | โ |
| Integrative analysis of miRNA expression profiles reveals distinct and common molecular mechanisms underlying broad diagnostic groups of severe mental disorders. | Solomon P et al. | โ | 2025 | โ |
| Is there a causal link between folate status and schizophrenia? Evidence from genetic association studies. | Yoo S et al. | โ | 2025 | โ |
| Local cortical structure pattern and genetic links in schizophrenia: An MRI and CRISPR/Cas9 study. | Hou PS et al. | โ | 2025 | โ |
| <i>Nkapl</i> deletion drives cognitive deficits through mPFC interneuron dysfunction in a mouse model of schizophrenia. | Yang Y et al. | โ | 2025 | โ |
| Meta-analysis of the brain transcriptomes of multiple genetic mouse models of schizophrenia highlights dysregulation in striatum and thalamus. | Perzel Mandell KA et al. | โ | 2025 | โ |
| Multitrait Analysis to Decipher the Intertwined Genetic Architecture of Neuroanatomical Phenotypes and Psychiatric Disorders. | Auvergne A et al. | โ | 2025 | โ |
| Multitrait Genetic Analysis Identifies Novel Pleiotropic Loci for Depression and Schizophrenia in East Asians. | Song Y et al. | โ | 2025 | โ |
| Neuronal Synaptic Communication and Mitochondrial Energetics in Human Health and Disease. | Glausier JR | โ | 2025 | โ |
| Painting psychosis: an empirical investigation of the self-portraits of Edvard Munch. | Bettelheim EC et al. | โ | 2025 | โ |
| Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring. | Milosavljevic S et al. | โ | 2025 | โ |
| Polygenic enrichment analysis in multi-omics levels identifies cell/tissue specific associations with schizophrenia based on single-cell RNA sequencing data. | Cheng B et al. | โ | 2025 | โ |
| Polygenic risk for schizophrenia is associated with white matter microstructure, cognitive and mental health. | Qian Q et al. | โ | 2025 | โ |
| Polygenic risk for schizophrenia predicting Big Five personality traits in individuals without non-affective psychosis. | Lavonius V et al. | โ | 2025 | โ |
| Psychiatric Antecedents in Adolescents at Clinical High Risk for Psychosis: Insights from the "Parma At-Risk Mental States" Follow-up Program. | Pelizza L et al. | โ | 2025 | โ |
| Recent findings and future directions for the intersection of genetic and environmental contributions to schizophrenia. | Robinson N et al. | โ | 2025 | โ |
| Reduced Cacna1c Expression Produces Anhedonic Reactions to Palatable Sucrose in Rats: No Interactions With Juvenile or Adult Stress. | Gasalla P et al. | โ | 2025 | โ |
| Repeated Clozapine Administration Causes Extensive Changes to the Expression of Coding and Non-coding RNAs, Including miR-124, in the Mouse Frontal Cortex. | Younis RM et al. | โ | 2025 | โ |
| Revealing the Oxidative Stress-Related Molecular Characteristics and Potential Therapeutic Targets of Schizophrenia through Integrated Gene Expression Data Analysis. | Zhu XM et al. | โ | 2025 | โ |
| Schizophrenia. | Leucht S et al. | โ | 2025 | โ |
| Schizophrenia genetic risk and labour market outcomes in the Finnish general population: Are schizophrenia-related traits penalised or rewarded? | Hazak A et al. | โ | 2025 | โ |
| Social cognitive deficits in schizophrenia, bipolar disorder, and first-degree relatives: A large-sample, multi-task investigation. | Blain SD et al. | โ | 2025 | โ |
| Somatic Mosaicism in Brain Disorders. | Corrigan RR et al. | โ | 2025 | โ |
| Spectral divergence prioritizes key classes, genes, and pathways shared between substance use disorders and cardiovascular disease. | Castaneda E et al. | โ | 2025 | โ |
| Structure of a polymorphic repeat at the <i>CACNA1C</i> schizophrenia locus. | Moya R et al. | โ | 2025 | โ |
| Synergistic SNP-SNP interaction of NRG1 and ERBB4 increases the risk of schizophrenia. | Norovsambuu O et al. | โ | 2025 | โ |
| The shared genetic architecture between schizophrenia and common peripheral organ imaging phenotypes. | Xie Y et al. | โ | 2025 | โ |
| The underlying neurobiological basis of gray matter volume alterations in schizophrenia with auditory verbal hallucinations: A meta-analytic investigation. | Xie Y et al. | โ | 2025 | โ |
| Transdiagnostic findings across major depressive disorder, bipolar disorder and schizophrenia: A qualitative review. | Stein F et al. | โ | 2025 | โ |
| Trends in schizophrenia-related mortality from 1999 to 2020: year, gender, and regional variations. | Bhatti HF et al. | โ | 2025 | โ |
| Understanding the Emergence of Schizophrenia in the Light of Human Evolution: New Perspectives in Genetics. | Sandroni V et al. | โ | 2025 | โ |
| Unravelling the genetic and molecular basis of low-frequency rTMS induced changes in functional connectivity density in schizophrenia patients with auditory verbal hallucinations. | Xie Y et al. | โ | 2025 | โ |
| Unveiling causal regulatory mechanisms through cell-state parallax. | Wu AP et al. | โ | 2025 | โ |
| Validity and reliability of the Box and Block Test for individuals with schizophrenia spectrum disorder. | Su JW et al. | โ | 2025 | โ |
| 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms. | Chen YH et al. | โ | 2024 | โ |
| Abnormalities in rich-club connections are associated with an exacerbation of genetic susceptibility to schizophrenia. | Li Y et al. | โ | 2024 | โ |
| Adverse childhood experiences differently affect Theory of Mind brain networks in schizophrenia and healthy controls. | Vai B et al. | โ | 2024 | โ |
| A miR-137-Related Biological Pathway of Risk forย Schizophrenia Is Associated With Human Brain Emotion Processing. | Pergola G et al. | โ | 2024 | โ |
| An Effective DNA Methylation Biomarker Screening Mechanism for Amyotrophic Lateral Sclerosis (ALS) Based on Comorbidities and Gene Function Analysis. | Yang CH et al. | โ | 2024 | โ |
| Association between the oral microbiome and brain resting state connectivity in schizophrenia. | Lin D et al. | โ | 2024 | โ |
| Case report: Rare variants in the <i>MTRR</i> gene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia. | Huang CC | โ | 2024 | โ |
| Case Studies on Dissocial Personality-Bad or Ill? | Sipowicz K et al. | โ | 2024 | โ |
| Co-expression of prepulse inhibition and Schizophrenia genes in the mouse and human brain. | Garrett L et al. | โ | 2024 | โ |
| Common risk alleles for schizophrenia within the major histocompatibility complex predict white matter microstructure. | Caseras X et al. | โ | 2024 | โ |
| Cortical Network Disruption Is Minimal in Early Stages of Psychosis. | Van Dyken PC et al. | โ | 2024 | โ |
| Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. | Johnson EC et al. | โ | 2024 | โ |
| Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview. | Choudhary A et al. | โ | 2024 | โ |
| Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia. | Zhou DY et al. | โ | 2024 | โ |
| Dietary habits and genetic susceptibility: correlations between nutritional intake and genetic risks for schizophrenia and bipolar disorder. | Ohi K et al. | โ | 2024 | โ |
| Differential depletion of GluN2A induces heterogeneous schizophrenia-related phenotypes in mice. | Lu Y et al. | โ | 2024 | โ |
| Discrimination between healthy participants and people with panic disorder based on polygenic scores for psychiatric disorders and for intermediate phenotypes using machine learning. | Ohi K et al. | โ | 2024 | โ |
| Enhancing schizophrenia phenotype prediction from genotype data through knowledge-driven deep neural network models. | Martins D et al. | โ | 2024 | โ |
| Environmental risk factors for schizophrenia and bipolar disorder from childhood to diagnosis: a Swedish nested case-control study. | Robinson N et al. | โ | 2024 | โ |
| Exploration of cell type-specific somatic mutations in schizophrenia and the impact of maternal immune activation on the somatic mutation profile in the brain. | Du J et al. | โ | 2024 | โ |
| Factor analysis of lifetime psychopathology and its brain morphometric and genetic correlates in a transdiagnostic sample. | Krug A et al. | โ | 2024 | โ |
| Familial Risk for Schizophrenia vs Bipolar Disorder and Task-Based Neural Activation: A functional Magnetic Resonance Imaging Meta-Analysis. | Rupert PE et al. | โ | 2024 | โ |
| Family-based genetic analysis in schizophrenia by whole-exome sequence to identify rare pathogenic variants. | Shang B et al. | โ | 2024 | โ |
| Generation of Human-induced Pluripotent Stem Cells Derived From Dermal Fibroblast of Schizophrenic Patients. | Parvishan A et al. | โ | 2024 | โ |
| Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia. | Cameron D et al. | โ | 2024 | โ |
| Genetic overlap between schizophrenia spectrum disorders and Alzheimer's disease: Current evidence and future directions - An integrative review. | Ohi K et al. | โ | 2024 | โ |
| Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders. | Luo J et al. | โ | 2024 | โ |
| Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder. | Ohi K et al. | โ | 2024 | โ |
| Hemorrhoidal disease and its genetic association with depression, bipolar disorder, anxiety disorders, and schizophrenia: a bidirectional mendelian randomization study. | Huang Z et al. | โ | 2024 | โ |
| Identification of a Predictive Model for Schizophrenia Based on SNPs in a Chinese Population. | Yang Z et al. | โ | 2024 | โ |
| Infants' looking preferences for social versus non-social objects reflect genetic variation. | Portugal AM et al. | โ | 2024 | โ |
| Influence of TMX2-CTNND1 polymorphism on cortical thickness in schizophrenia patients and unaffected siblings: an exploratory study based on target region sequencing. | Tan W et al. | โ | 2024 | โ |
| Involvement of the Expression of G Protein-Coupled Receptors in Schizophrenia. | Kalinovic R et al. | โ | 2024 | โ |
| Leveraging DNA methylation to predict treatment response in major depressive disorder: A critical review. | Dahrendorff J et al. | โ | 2024 | โ |
| Luxenburger's 1939 Essay on "Schizophrenia and its Hereditary Circle". | Kendler KS et al. | โ | 2024 | โ |
| Maternal vitamin D levels during pregnancy and offspring schizophrenia. | Sourander A et al. | โ | 2024 | โ |
| MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment. | Martinez B et al. | โ | 2024 | โ |
| New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment. | Faris P et al. | โ | 2024 | โ |
| NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia. | Almodรณvar-Payรก C et al. | โ | 2024 | โ |
| Polygenic effects on brain functional endophenotype for deficit and non-deficit schizophrenia. | Fang J et al. | โ | 2024 | โ |
| Polygenic risk for schizophrenia predicting social trajectories in a general population sample. | Saarinen A et al. | โ | 2024 | โ |
| Polygenic risk for schizophrenia, social dispositions, and pace of epigenetic aging: Results from the Young Finns Study. | Saarinen A et al. | โ | 2024 | โ |
| Polygenic Risk Scores and Twin Concordance for Schizophrenia and Bipolar Disorder. | Song J et al. | โ | 2024 | โ |
| Psychotic Disorders and exosomes: An overview of current evidence and future directions. | Desmeules C et al. | โ | 2024 | โ |
| Schizophrenia and Bone Marrow Disorders: An Emerging Clinical Association. | Jayakumar J et al. | โ | 2024 | โ |
| Schizophrenia genomics: genetic complexity and functional insights. | Sullivan PF et al. | โ | 2024 | โ |
| Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades. | Villanueva R | โ | 2024 | โ |
| Study of the genetic association between selected 3q29 region genes and schizophrenia and autism spectrum disorder in the Japanese population. | Otgonbayar G et al. | โ | 2024 | โ |
| The complement system in neurodegenerative diseases. | Nimmo J et al. | โ | 2024 | โ |
| The impact of treating parental bipolar disorder and schizophrenia on their children's mental health and wellbeing: an empty systematic review. | Can B et al. | โ | 2024 | โ |
| The Intergenerational Transfer of Mental Disorders: A Population-Based Multigenerational Linkage Study: Le transfert intergรฉnรฉrationnel des troubles mentaux : une รฉtude sur les liens multigรฉnรฉrationnels basรฉe sur la population. | Hamad AF et al. | โ | 2024 | โ |
| The neuromuscular basis of functional impairment in schizophrenia: A scoping review. | Raj V et al. | โ | 2024 | โ |
| The neuropsychopharmacology of acetyl-L-carnitine (LAC): basic, translational and therapeutic implications. | Bigio B et al. | โ | 2024 | โ |
| The neutrophil-lymphocyte ratio in first-episode medication-naรฏve patients with schizophrenia: A 12-week longitudinal follow-up study. | Lu X et al. | โ | 2024 | โ |
| The problem with genetic heritability estimates in psychiatry: 'missing heritability' or missed cross-cultural environmental variation? | Gillett G | โ | 2024 | โ |
| Therapeutic potential of gamma entrainment using sensory stimulation for cognitive symptoms associated with schizophrenia. | Black T et al. | โ | 2024 | โ |
| The relationship between familial-genetic risk and pharmacological treatment in a Swedish national sample of patients with major depression, bipolar disorder, and schizophrenia. | Kendler KS et al. | โ | 2024 | โ |
| The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. | Tandon R et al. | โ | 2024 | โ |
| The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence. | Cullen AE et al. | โ | 2024 | โ |
| Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis. | Corsi-Zuelli F et al. | โ | 2024 | โ |
| Untangling Depression in Schizophrenia: The Role of Disorganized and Obsessive-Compulsive Symptoms and the Duration of Untreated Psychosis. | Panov G et al. | โ | 2024 | โ |
| A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome. | Schmitt JE et al. | โ | 2023 | โ |
| Alterations in microRNA of extracellular vesicles associated with major depression, attention-deficit/hyperactivity and anxiety disorders in adolescents. | Honorato-Mauer J et al. | โ | 2023 | โ |
| [An analysis of the relationship between genetic factors and the risk of schizophrenia]. | Shmakova AA et al. | โ | 2023 | โ |
| Biological hypotheses, risk factors, and biomarkers of schizophrenia. | Fiลกar Z | โ | 2023 | โ |
| Blood-Based MicroRNAs in Psychotic Disorders-A Systematic Review. | Grosu ศA et al. | โ | 2023 | โ |
| Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice. | Farsi Z et al. | โ | 2023 | โ |
| Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis. | Oscoz-Irurozqui M et al. | โ | 2023 | โ |
| Changes in patterns of age-related network connectivity are associated with risk for schizophrenia. | Passiatore R et al. | โ | 2023 | โ |
| Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol. | Agarwal SM et al. | โ | 2023 | โ |
| Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors. | Rรธdevand L et al. | โ | 2023 | โ |
| Clinical characteristics indexing genetic differences in schizophrenia: a systematic review. | Taylor J et al. | โ | 2023 | โ |
| Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. | McCutcheon RA et al. | โ | 2023 | โ |
| Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach. | Ohi K et al. | โ | 2023 | โ |
| Common genetic variants contribute to heritability of age at onset of schizophrenia. | Sada-Fuente E et al. | โ | 2023 | โ |
| Copy Number Variations in Neuropsychiatric Disorders. | Bรผki G et al. | โ | 2023 | โ |
| Current State of Modeling Human Psychiatric Disorders Using Zebrafish. | Costa FV et al. | โ | 2023 | โ |
| De novo mutations disturb early brain development more frequently than common variants in schizophrenia. | Itai T et al. | โ | 2023 | โ |
| Disease-specific resting-state EEG network variations in schizophrenia revealed by the contrastive machine learning. | Li F et al. | โ | 2023 | โ |
| Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia. | Ben-Azu B et al. | โ | 2023 | โ |
| Evaluation of the Effect of Barberry Root (Berberis Vulgaris) on the Prevention of Metabolic Syndrome Caused by Atypical Antipsychotic Drugs in Patients with Schizophrenia: A Three-Blind Placebo-Controlled Clinical Trial. | Rostami H et al. | โ | 2023 | โ |
| Excitatory Dysfunction Drives Network and Calcium Handling Deficits in 16p11.2 Duplication Schizophrenia Induced Pluripotent Stem Cell-Derived Neurons. | Parnell E et al. | โ | 2023 | โ |
| Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data. | de Sousa TR et al. | โ | 2023 | โ |
| Focusing on modifiable early protective factors to prevent negative neurodevelopmental and psychiatric outcomes in at-risk infants. | Poletti M et al. | โ | 2023 | โ |
| Gene Expressions Preferentially Influence Cortical Thickness of Human Connectome Project Atlas Parcellated Regions in First-Episode Antipsychotic-Naรฏve Psychoses. | McGuigan BN et al. | โ | 2023 | โ |
| Genetic and Epigenetic Regulation in <i>Lingo-1</i>: Effects on Cognitive Function and White Matter Microstructure in a Case-Control Study for Schizophrenia. | Andrews JL et al. | โ | 2023 | โ |
| Genetic Influences on Cognitive Dysfunction in Schizophrenia. | Greenwood TA | โ | 2023 | โ |
| Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus. | Wang J et al. | โ | 2023 | โ |
| Genome-wide association study identified six loci associated with adverse drug reactions to aripiprazole in schizophrenia patients. | Wang X et al. | โ | 2023 | โ |
| Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. | Liu J et al. | โ | 2023 | โ |
| Genomic findings in schizophrenia and their implications. | Owen MJ et al. | โ | 2023 | โ |
| Human-specific evolutionary markers linked to foetal neurodevelopment modulate brain surface area in schizophrenia. | Guardiola-Ripoll M et al. | โ | 2023 | โ |
| <i>BDNF</i> rs962369 Is Associated with Major Depressive Disorder. | Bednรกลovรก A et al. | โ | 2023 | โ |
| Identification of <i>VIPR2</i> rare and common variants in the Chinese Han population with schizophrenia. | Yin J et al. | โ | 2023 | โ |
| Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. | Funahashi Y et al. | โ | 2023 | โ |
| Impact of Early-Life Factors on Risk for Schizophrenia and Bipolar Disorder. | Robinson N et al. | โ | 2023 | โ |
| Impaired mnemonic discrimination in children and adolescents at risk for schizophrenia. | ฤฐmamoฤlu A et al. | โ | 2023 | โ |
| Indicators of HSV1 Infection, ECM-Receptor Interaction, and Chromatin Modulation in a Nuclear Family with Schizophrenia. | Huang YC et al. | โ | 2023 | โ |
| Inferring disease architecture and predictive ability with LDpred2-auto. | Privรฉ F et al. | โ | 2023 | โ |
| In memory of Professor Iain Wilkinson: cognitive and neuroimaging endophenotypes in a consanguineous schizophrenia multiplex family. | Wilkinson ID et al. | โ | 2023 | โ |
| Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. | Johnson EC et al. | โ | 2023 | โ |
| Lessons Learned From Parsing Genetic Risk for Schizophrenia Into Biological Pathways. | Pergola G et al. | โ | 2023 | โ |
| miR-9-5p deficiency contributes to schizophrenia. | Fu X et al. | โ | 2023 | โ |
| Mitochondrial DNA Copy Number and Heteroplasmy in Monozygotic Twins Discordant for Schizophrenia. | Win PW et al. | โ | 2023 | โ |
| Mitochondrial genetic variants associated with bipolar disorder and Schizophrenia in a Japanese population. | Tachi R et al. | โ | 2023 | โ |
| Molecular mechanisms of schizophrenia: Insights from human genetics. | Farsi Z et al. | โ | 2023 | โ |
| Molecules Affecting Brain Development and Nervous System. | Nakadate K et al. | โ | 2023 | โ |
| MR-DoC2: Bidirectional Causal Modeling with Instrumental Variables and Data from Relatives. | Castro-de-Araujo LFS et al. | โ | 2023 | โ |
| Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors. | Schmitt A et al. | โ | 2023 | โ |
| New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications. | Andreassen OA et al. | โ | 2023 | โ |
| Pharmaco-genetic analysis of <i>CYP1A1</i> and <i>RGS4</i> variants and its impact on response to olanzapine and risperidone in Indian schizophrenic cohort. | Garg R et al. | โ | 2023 | โ |
| Polygenic risk, familial liability and stress reactivity in psychosis: an experience sampling study. | Schick A et al. | โ | 2023 | โ |
| Polygenic risk scores for schizophrenia are associated with oculomotor endophenotypes. | Coors A et al. | โ | 2023 | โ |
| Rare tandem repeat expansions associate with genes involved in synaptic and neuronal signaling functions in schizophrenia. | Wen J et al. | โ | 2023 | โ |
| Recent advances in dopamine D<sub>2</sub> receptor ligands in the treatment of neuropsychiatric disorders. | Juza R et al. | โ | 2023 | โ |
| Rediscovering tandem repeat variation in schizophrenia: challenges and opportunities. | Birnbaum R | โ | 2023 | โ |
| Schizophrenia, Human Leukocyte Antigen (HLA), and Herpes Viruses: Immunogenetic Associations at the Population Level. | James LM et al. | โ | 2023 | โ |
| Schizophrenia polygenic risk score and type 2 diabetes onset in older adults with no schizophrenia diagnosis. | Shamsutdinova D et al. | โ | 2023 | โ |
| Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case-control association study. | Mukhopadhyay A et al. | โ | 2023 | โ |
| Single-Nuclei RNA Sequencing of 5 Regions of the Human Prenatal Brain Implicates Developing Neuron Populations in Genetic Risk for Schizophrenia. | Cameron D et al. | โ | 2023 | โ |
| Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study. | Rogdaki M et al. | โ | 2023 | โ |
| Study protocol of the Berlin Research Initiative for Diagnostics, Genetics and Environmental Factors in Schizophrenia (BRIDGE-S). | Braun A et al. | โ | 2023 | โ |
| Systematic investigation of allelic regulatory activity of schizophrenia-associated common variants. | McAfee JC et al. | โ | 2023 | โ |
| The contribution of copy number variants to psychiatric symptoms and cognitive ability. | Mollon J et al. | โ | 2023 | โ |
| The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia. | Misiak B et al. | โ | 2023 | โ |
| The genetic architecture of schizophrenia: review of large-scale genetic studies. | Kato H et al. | โ | 2023 | โ |
| The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia. | Matuszewska A et al. | โ | 2023 | โ |
| The molecular pathology of schizophrenia: an overview of existing knowledge and new directions for future research. | Nakamura T et al. | โ | 2023 | โ |
| Whole Genome Sequencing Revealed Inherited Rare Oligogenic Variants Contributing to Schizophrenia and Major Depressive Disorder in Two Families. | Chung IH et al. | โ | 2023 | โ |
| YBX1-Mediated DNA Methylation-Dependent SHANK3 Expression in PBMCs and Developing Cortical Interneurons in Schizophrenia. | Ni P et al. | โ | 2023 | โ |
| A comparative study to determine the association of gut microbiome with schizophrenia in Zhejiang, China. | Yan F et al. | โ | 2022 | โ |
| A comprehensive map of genetic relationships among diagnostic categories based on 48.6 million relative pairs from the Danish genealogy. | Athanasiadis G et al. | โ | 2022 | โ |
| Adolescent Verbal Memory as a Psychosis Endophenotype: A Genome-Wide Association Study in an Ancestrally Diverse Sample. | Wang B et al. | โ | 2022 | โ |
| A family study on first episode of psychosis patients: Exploring neuropsychological performance as an endophenotype. | Murillo-Garcรญa N et al. | โ | 2022 | โ |
| A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A). | Guardiola-Ripoll M et al. | โ | 2022 | โ |
| Age at Separation of Twin Pairs in the FinnTwin12 Study. | Wang Z et al. | โ | 2022 | โ |
| Altered Intestinal Permeability Biomarkers in Schizophrenia: A Possible Link with Subclinical Inflammation. | Gokulakrishnan K et al. | โ | 2022 | โ |
| Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia. | Saleem A et al. | โ | 2022 | โ |
| An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data. | Zhang CY et al. | โ | 2022 | โ |
| Association Between Childhood Exposure to Pet Cats and Later Diagnosis of Schizophrenia: A Case-Control Study in Saudi Arabia. | Hakami RM et al. | โ | 2022 | โ |
| Association between MTHFR (677C>T and 1298A>C) polymorphisms and psychiatric disorder: A meta-analysis. | Meng X et al. | โ | 2022 | โ |
| Associations between polygenic risk scores and amplitude of low-frequency fluctuation of inferior frontal gyrus in schizophrenia. | Kang J et al. | โ | 2022 | โ |
| Autism spectrum disorder and schizophrenia: An updated conceptual review. | Jutla A et al. | โ | 2022 | โ |
| Brain structural abnormalities of the associative striatum in adolescents and young adults at genetic high-risk of schizophrenia: Implications for illness endophenotypes. | Nestor PG et al. | โ | 2022 | โ |
| Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls. | Ferretjans R et al. | โ | 2022 | โ |
| Cell type-specific mechanism of Setd1a heterozygosity in schizophrenia pathogenesis. | Chen R et al. | โ | 2022 | โ |
| Common Genetic Variation and Age of Onset of Anorexia Nervosa. | Watson HJ et al. | โ | 2022 | โ |
| Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits. | Lencz T et al. | โ | 2022 | โ |
| Deregulatory miRNA-BDNF Network Inferred from Dynamic Expression Changes in Schizophrenia. | Fu X et al. | โ | 2022 | โ |
| Derivation and utility of schizophrenia polygenic risk associated multimodal MRI frontotemporal network. | Qi S et al. | โ | 2022 | โ |
| Development of the Korea-Polyenvironmental Risk Score for Psychosis. | Jeon EJ et al. | โ | 2022 | โ |
| Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls. | Ohi K et al. | โ | 2022 | โ |
| Distinctively lower DISC1 mRNA levels in patients with schizophrenia, especially in those with higher positive, negative, and depressive symptoms. | Chen YM et al. | โ | 2022 | โ |
| DNA Banking to Assess Genetic Influences on Schizophrenia. | Sadighi G et al. | โ | 2022 | โ |
| DNA Methylation Markers and Prediction Model for Depression and Their Contribution for Breast Cancer Risk. | Wang N et al. | โ | 2022 | โ |
| Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity. | Zhao W et al. | โ | 2022 | โ |
| Effects of polygenic risk for major mental disorders and cross-disorder on cortical complexity. | Schmitt S et al. | โ | 2022 | โ |
| Effects of psychosis-associated genetic markers on brain volumetry: a systematic review of replicated findings and an independent validation. | Vouga Ribeiro N et al. | โ | 2022 | โ |
| Embedded figures in schizophrenia: A main deficit but no specificity. | Favrod O et al. | โ | 2022 | โ |
| Functional characterization of the schizophrenia associated gene AS3MT identifies a role in neuronal development. | Washer SJ et al. | โ | 2022 | โ |
| Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1. | Wang J et al. | โ | 2022 | โ |
| Gene-Environment Correlation over Time: A Longitudinal Analysis of Polygenic Risk Scores for Schizophrenia and Major Depression in Three British Cohorts Studies. | Machlitt-Northen S et al. | โ | 2022 | โ |
| Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum. | Abrantes A et al. | โ | 2022 | โ |
| Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci. | Wistrรถm ED et al. | โ | 2022 | โ |
| Genome-wide association studies-supported rs12966547 variant of the long noncoding RNA LOC105372125 is significantly associated with susceptibility to schizophrenia and bipolar disorder in Han Chinese women. | Zhao Z et al. | โ | 2022 | โ |
| Genome-wide DNA methylation in an animal model and human studies of schizophrenia: a protocol for a meta-analysis. | Magwai T et al. | โ | 2022 | โ |
| Glutamatergic dysfunction in Schizophrenia. | Kruse AO et al. | โ | 2022 | โ |
| Heritability of specific cognitive functions and associations with schizophrenia spectrum disorders using CANTAB: a nation-wide twin study. | Lemvigh CK et al. | โ | 2022 | โ |
| Heritability: What's the point? What is it not for? A human genetics perspective. | Robette N et al. | โ | 2022 | โ |
| Heritable anisotropy associated with cognitive impairments among patients with schizophrenia and their non-psychotic relatives in multiplex families. | Prasad KM et al. | โ | 2022 | โ |
| How can we obtain truly translational mouse models to improve clinical outcomes in schizophrenia? | Clapcote SJ | โ | 2022 | โ |
| Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data. | Gu X et al. | โ | 2022 | โ |
| Impact of schizophrenia GWAS loci converge onto distinct pathways in cortical interneurons vs glutamatergic neurons during development. | Liu D et al. | โ | 2022 | โ |
| Influences on the Genetic Relationship Between Cannabis Use and Schizophrenia: The Role of the Externalizing Spectrum. | Wormington B et al. | โ | 2022 | โ |
| <i>NRN1</i> Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches. | Almodรณvar-Payรก C et al. | โ | 2022 | โ |
| Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction. | Guan F et al. | โ | 2022 | โ |
| Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt. | Jeremian R et al. | โ | 2022 | โ |
| Investigation of <i>OLIG2</i> as a candidate gene for schizophrenia and autism spectrum disorder. | Furuta S et al. | โ | 2022 | โ |
| Involvement of the long intergenic non-coding RNA LINC00461 in schizophrenia. | Rao S et al. | โ | 2022 | โ |
| L1 Retrotransposons: A Potential Endogenous Regulator for Schizophrenia. | Jahangir M et al. | โ | 2022 | โ |
| Leveraging interindividual variability of regulatory activity for refining genetic regulation of gene expression in schizophrenia. | Alver M et al. | โ | 2022 | โ |
| Mapping miRNA Research in Schizophrenia: A Scientometric Review. | Lim M et al. | โ | 2022 | โ |
| Multi-modal intermediate integrative methods in neuropsychiatric disorders: A review. | Wang Y et al. | โ | 2022 | โ |
| New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study. | Guardiola-Ripoll M et al. | โ | 2022 | โ |
| Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants. | Zhang R et al. | โ | 2022 | โ |
| Novel IL1RAP mutation associated with schizophrenia interferes with neuronal growth and related NF-ฮบB signal pathways. | Cheng P et al. | โ | 2022 | โ |
| Novel open reading frames in human accelerated regions and transposable elements reveal new leads to understand schizophrenia and bipolar disorder. | Erady C et al. | โ | 2022 | โ |
| Overlap between genetic variants associated with schizophrenia spectrum disorders and intelligence quotient: a systematic review. | Murillo-Garcรญa N et al. | โ | 2022 | โ |
| Perceptions of causal attribution and attitudes to genetic testing among people with schizophrenia and their first-degree relatives. | Cullen MBR et al. | โ | 2022 | โ |
| Pharmacogenetics and Schizophrenia-Can Genomics Improve the Treatment with Second-Generation Antipsychotics? | Pลaza O et al. | โ | 2022 | โ |
| Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy Individuals. | Koch E et al. | โ | 2022 | โ |
| Polygenic risk scores for schizophrenia and major depression are associated with socio-economic indicators of adversity in two British community samples. | Machlitt-Northen S et al. | โ | 2022 | โ |
| Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene-environment correlation. | Machlitt-Northen S et al. | โ | 2022 | โ |
| Quantifying the heritability of belief formation. | Vellani V et al. | โ | 2022 | โ |
| Recent Advances and Future Directions in Brain MR Imaging Studies in Schizophrenia: Toward Elucidating Brain Pathology and Developing Clinical Tools. | Koike S et al. | โ | 2022 | โ |
| Regulatory Variant rs2535629 in ITIH3 Intron Confers Schizophrenia Risk By Regulating CTCF Binding and SFMBT1 Expression. | Li Y et al. | โ | 2022 | โ |
| Regulatory variants at 2q33.1 confer schizophrenia risk by modulating distal gene TYW5 expression. | Li S et al. | โ | 2022 | โ |
| Reprint of: Elemental dysregulation in psychotic spectrum disorders: A review and research synthesis. | Zaks N et al. | โ | 2022 | โ |
| Research Review: How to interpret associations between polygenic scores, environmental risks, and phenotypes. | Pingault JB et al. | โ | 2022 | โ |
| Revisiting tandem repeats in psychiatric disorders from perspectives of genetics, physiology, and brain evolution. | Xiao X et al. | โ | 2022 | โ |
| Roles of neuroligins in central nervous system development: focus on glial neuroligins and neuron neuroligins. | Liu X et al. | โ | 2022 | โ |
| Schizophrenia. | Jauhar S et al. | โ | 2022 | โ |
| Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models. | Wegrzyn D et al. | โ | 2022 | โ |
| Structural covariance networks in schizophrenia: A systematic review Part II. | Prasad K et al. | โ | 2022 | โ |
| Supplementation of PQQ from pregnancy prevents MK-801-induced schizophrenia-like behaviors in mice. | Peng Y et al. | โ | 2022 | โ |
| The beginnings of biometrical psychiatric genetics: Studies of the insane diathesis 1905-1909. | Kendler KS | โ | 2022 | โ |
| The Beginnings of Scientific Psychiatric Twin Research: Luxenburger's 1928 "Preliminary Report on the Psychiatric Examination of a Series of Twins". | Kendler KS et al. | โ | 2022 | โ |
| The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study. | Song J et al. | โ | 2022 | โ |
| The Neuropsychiatric Approach to the Assessment of Patients in Neurology. | Trapp NT et al. | โ | 2022 | โ |
| The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders. | Zhang K et al. | โ | 2022 | โ |
| Third-generation genome sequencing implicates medium-sized structural variants in chronic schizophrenia. | Lee CC et al. | โ | 2022 | โ |
| Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants. | Sanders B et al. | โ | 2022 | โ |
| Working memory deficits in children with schizophrenia and its mechanism, susceptibility genes, and improvement: A literature review. | Zhou J et al. | โ | 2022 | โ |
| 3D promoter architecture re-organization during iPSC-derived neuronal cell differentiation implicates target genes for neurodevelopmental disorders. | Su C et al. | โ | 2021 | โ |
| Advances in Proteomics Allow Insights Into Neuronal Proteomes. | Fingleton E et al. | โ | 2021 | โ |
| A genetic risk score using human chromosomal-scale length variation can predict schizophrenia. | Toh C et al. | โ | 2021 | โ |
| A Human-Specific Schizophrenia Risk Tandem Repeat Affects Alternative Splicing of a Human-Unique Isoform AS3MTd2d3 and Mushroom Dendritic Spine Density. | Cai X et al. | โ | 2021 | โ |
| Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study. | Liu Y et al. | โ | 2021 | โ |
| Alterations in hippocampal subfield volumes among schizophrenia patients, their first-degree relatives and healthy subjects. | Ohi K et al. | โ | 2021 | โ |
| Alternative models for transgenerational epigenetic inheritance: Molecular psychiatry beyond mice and man. | Hime GR et al. | โ | 2021 | โ |
| A machine learning case-control classifier for schizophrenia based on DNA methylation in blood. | Gunasekara CJ et al. | โ | 2021 | โ |
| Analysis of Major Depression Risk Genes Reveals Evolutionary Conservation, Shared Phenotypes, and Extensive Genetic Interactions. | Sall S et al. | โ | 2021 | โ |
| Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations. | Lรคhteenvuo M et al. | โ | 2021 | โ |
| Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia. | Michael Deans PJ et al. | โ | 2021 | โ |
| A Recessively Inherited Risk Locus on Chromosome 13q22-31 Conferring Susceptibility to Schizophrenia. | Mahmood T et al. | โ | 2021 | โ |
| Association between rs1344706 Polymorphism in the ZNF804A Gene and the Risk for Schizophrenia. | Esmaeili A et al. | โ | 2021 | โ |
| A unique missense variant in the E1A-binding protein P400 gene is implicated in schizophrenia by whole-exome sequencing and mutant mouse models. | Morimoto Y et al. | โ | 2021 | โ |
| Axonal branch patterning and neuronal shape diversity: roles in developmental circuit assembly: Axonal branch patterning and neuronal shape diversity in developmental circuit assembly. | Hoersting AK et al. | โ | 2021 | โ |
| Brain gene co-expression networks link complement signaling with convergent synaptic pathology in schizophrenia. | Kim M et al. | โ | 2021 | โ |
| Causal associations of intelligence with schizophrenia and bipolar disorder: A Mendelian randomization analysis. | Ohi K et al. | โ | 2021 | โ |
| Characteristics of Multimodal Brain Connectomics in Patients With Schizophrenia and the Unaffected First-Degree Relatives. | Lin X et al. | โ | 2021 | โ |
| Convergent lines of evidence support <i>NOTCH4</i> as a schizophrenia risk gene. | Zhang Y et al. | โ | 2021 | โ |
| Deficit syndrome in Chinese patients with first-episode drug naรฏve schizophrenia: Prevalence, demographic and clinical characteristics. | Liu J et al. | โ | 2021 | โ |
| Detection of Morphological Abnormalities in Schizophrenia: An Important Step to Identify Associated Genetic Disorders or Etiologic Subtypes. | Priol AC et al. | โ | 2021 | โ |
| Disorganization of Oscillatory Activity in Animal Models of Schizophrenia. | Speers LJ et al. | โ | 2021 | โ |
| Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. | Buch AM et al. | โ | 2021 | โ |
| DNA Methylation and Schizophrenia: Current Literature and Future Perspective. | Magwai T et al. | โ | 2021 | โ |
| DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia. | Hannon E et al. | โ | 2021 | โ |
| EEG Microstates and Psychosocial Stress During an Exchange Year. | Kadier N et al. | โ | 2021 | โ |
| Effects of genomic copy number variants penetrant for schizophrenia on cortical thickness and surface area in healthy individuals: analysis of the UK Biobank. | Caseras X et al. | โ | 2021 | โ |
| Elemental dysregulation in psychotic spectrum disorders: A review and research synthesis. | Zaks N et al. | โ | 2021 | โ |
| Elevated levels of IL-18 associated with schizophrenia and first episode psychosis: A systematic review and meta-analysis. | Syed AAS et al. | โ | 2021 | โ |
| Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions. | Robinson N et al. | โ | 2021 | โ |
| Estimating Aggregate Environmental Risk Score in Psychiatry: The Exposome Score for Schizophrenia. | Pries LK et al. | โ | 2021 | โ |
| Familial co-aggregation of schizophrenia and eating disorders in Sweden and Denmark. | Zhang R et al. | โ | 2021 | โ |
| Functional Analysis of <i>DNMT1</i> SNPs (<i>rs2228611</i> and <i>rs2114724</i>) Associated with Schizophrenia. | Saxena S et al. | โ | 2021 | โ |
| Functional variants fine-mapping and gene function characterization provide insights into the role of ZNF323 in schizophrenia pathogenesis. | Li S et al. | โ | 2021 | โ |
| FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors. | Shen M et al. | โ | 2021 | โ |
| GABAergic System Dysfunction and Challenges in Schizophrenia Research. | Jahangir M et al. | โ | 2021 | โ |
| Generative network models of altered structural brain connectivity in schizophrenia. | Zhang X et al. | โ | 2021 | โ |
| Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness. | Cheng W et al. | โ | 2021 | โ |
| Genetic contributions to anxiety disorders: where we are and where we are heading. | Ask H et al. | โ | 2021 | โ |
| Genetic underpinnings of schizophrenia-related electroencephalographical intermediate phenotypes: A systematic review and meta-analysis. | Hederih J et al. | โ | 2021 | โ |
| Genome-wide analyses of smoking behaviors in schizophrenia: Findings from the Psychiatric Genomics Consortium. | Peterson RE et al. | โ | 2021 | โ |
| Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia. | Liu J et al. | โ | 2021 | โ |
| Genome wide association study identifies four loci for early onset schizophrenia. | Guo S et al. | โ | 2021 | โ |
| Genomic perspectives on the circadian clock hypothesis of psychiatric disorders. | von Schantz M et al. | โ | 2021 | โ |
| Global Scientific Outputs of Schizophrenia Publications From 1975 to 2020: a Bibliometric Analysis. | Kiraz S et al. | โ | 2021 | โ |
| Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant Schizophrenia. | Iwata Y et al. | โ | 2021 | โ |
| Grey and white matter microstructure is associated with polygenic risk for schizophrenia. | Stauffer EM et al. | โ | 2021 | โ |
| Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics? | Munawar N et al. | โ | 2021 | โ |
| High-impact rare genetic variants in severe schizophrenia. | Zoghbi AW et al. | โ | 2021 | โ |
| How do established developmental risk-factors for schizophrenia change the way the brain develops? | Eyles DW | โ | 2021 | โ |
| Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT's Role in Complex Brain Disorders and Neurological Disease. | Levenga J et al. | โ | 2021 | โ |
| Infections, antibiotic treatment and the Microbiome in relation to schizophrenia. | Klein-Petersen AW et al. | โ | 2021 | โ |
| <i>NLRP3</i> Influences Cognitive Function in Schizophrenia in Han Chinese. | Liu R et al. | โ | 2021 | โ |
| Integrative Analyses Followed by Functional Characterization Reveal TMEM180 as a Schizophrenia Risk Gene. | Wang JY et al. | โ | 2021 | โ |
| KALRN: A central regulator of synaptic function and synaptopathies. | Parnell E et al. | โ | 2021 | โ |
| Low-Level Brain Somatic Mutations Are Implicated in Schizophrenia. | Kim MH et al. | โ | 2021 | โ |
| Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia. | Maini K et al. | โ | 2021 | โ |
| MAD1L1 and TSNARE gene polymorphisms are associated with schizophrenia susceptibility in the Han Chinese population. | Liu X et al. | โ | 2021 | โ |
| Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. | Nabais MF et al. | โ | 2021 | โ |
| MicroRNAs in the Onset of Schizophrenia. | Thomas KT et al. | โ | 2021 | โ |
| Neanderthal-derived genetic variation in living humans relates to schizophrenia diagnosis, to psychotic symptom severity, and to dopamine synthesis. | Gregory MD et al. | โ | 2021 | โ |
| Network modules linking expression and methylation in prefrontal cortex of schizophrenia. | Lin D et al. | โ | 2021 | โ |
| Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions. | Tromp A et al. | โ | 2021 | โ |
| [Neurodevelopmental Disorders, Psychiatric Comorbidities and Associated Pathologies in Patients with Childhood-Onset Schizophrenia and Premorbid Autistic Symptoms.] | Fernandez A et al. | โ | 2021 | โ |
| Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome. | Hwang H et al. | โ | 2021 | โ |
| No causal associations between childhood family income and subsequent psychiatric disorders, substance misuse and violent crime arrests: a nationwide Finnish study of >650ย 000 individuals and their siblings. | Sariaslan A et al. | โ | 2021 | โ |
| Novel ultra-rare exonic variants identified in a founder population implicate cadherins in schizophrenia. | Lencz T et al. | โ | 2021 | โ |
| Oxidative stress and schizophrenia: A comparative cross-sectional study of multiple oxidative markers in patients and their first-degree relatives. | Guler EM et al. | โ | 2021 | โ |
| Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways. | MacDowell KS et al. | โ | 2021 | โ |
| Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects. | Ohi K et al. | โ | 2021 | โ |
| Postnatal therapeutic approaches in genetic neurodevelopmental disorders. | Levy G et al. | โ | 2021 | โ |
| Psychotic-Like Experiences in Adolescence Occurring in Combination or Isolation: Associations with Schizophrenia Risk Factors. | Cardno AG et al. | โ | 2021 | โ |
| Rare germline variants in individuals diagnosed with schizophrenia within multiplex families. | Li S et al. | โ | 2021 | โ |
| Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study. | Yu W et al. | โ | 2021 | โ |
| Schizophrenia-associated variation at ZNF804A correlates with altered experience-dependent dynamics of sleep slow waves and spindles in healthy young adults. | Bartsch U et al. | โ | 2021 | โ |
| Schizophrenia: Complement Cleaning or Killing. | Hogenaar JTT et al. | โ | 2021 | โ |
| Sex specific effect of gut microbiota on the risk of psychiatric disorders: A Mendelian randomisation study and PRS analysis using UK Biobank cohort. | Qi X et al. | โ | 2021 | โ |
| Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals. | Koch E et al. | โ | 2021 | โ |
| Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders. | Zhang Y et al. | โ | 2021 | โ |
| The clinical, imaging and biological features of psychosis in Han Chinese patients with Huntington's disease. | Li XY et al. | โ | 2021 | โ |
| The Stop Signal Task for Measuring Behavioral Inhibition in Mice With Increased Sensitivity and High-Throughput Operation. | Caglayan A et al. | โ | 2021 | โ |
| Transcriptome-Wide Association Study Provides Insights Into the Genetic Component of Gene Expression in Anxiety. | Su X et al. | โ | 2021 | โ |
| Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder. | Reis de Assis D et al. | โ | 2021 | โ |
| Utility of polygenic embryo screening for disease depends on the selection strategy. | Lencz T et al. | โ | 2021 | โ |
| Weak Association Between the Glutamate Decarboxylase 1 Gene (GAD1) and Schizophrenia in Han Chinese Population. | Zhang L et al. | โ | 2021 | โ |
| Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study. | Ruiz-Sรกnchez E et al. | โ | 2021 | โ |
| Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models. | Dunn AL et al. | โ | 2020 | โ |
| Adverse childhood experiences lead to trans-generational transmission of early maladaptive schemas. | Zeynel Z et al. | โ | 2020 | โ |
| Alteration of the gut microbiome in first-episode drug-naรฏve and chronic medicated schizophrenia correlate with regional brain volumes. | Ma X et al. | โ | 2020 | โ |
| Analysis of KCNH2 and CACNA1C schizophrenia risk genes on EEG functional network modulation during an auditory odd-ball task. | Lubeiro A et al. | โ | 2020 | โ |
| ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk. | Sekiguchi M et al. | โ | 2020 | โ |
| Assessment Causality in Associations Between Serum Uric Acid and Risk of Schizophrenia: A Two-Sample Bidirectional Mendelian Randomization Study. | Luo Q et al. | โ | 2020 | โ |
| Association between a <i>TCF4</i> Polymorphism and Susceptibility to Schizophrenia. | Gao JY et al. | โ | 2020 | โ |
| Association Between Childhood Green Space, Genetic Liability, and the Incidence of Schizophrenia. | Engemann K et al. | โ | 2020 | โ |
| Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia. | Michalczyk A et al. | โ | 2020 | โ |
| Association between functional and structural connectivity of the corticostriatal network in people with schizophrenia and unaffected first-degree relatives. | Li P et al. | โ | 2020 | โ |
| Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population. | Yan C et al. | โ | 2020 | โ |
| Association between <i>EFHD2</i> gene polymorphisms and schizophrenia among the Han population in northern China. | Gao M et al. | โ | 2020 | โ |
| Association between polygenic liability for schizophrenia and substance involvement: A nationwide population-based study in Taiwan. | Wang SH et al. | โ | 2020 | โ |
| Association between Serum Essential Metal Elements and the Risk of Schizophrenia in China. | Ma J et al. | โ | 2020 | โ |
| Association of ADH7 Gene Polymorphism with Schizophrenia in the Han Population of Northern China: a Case-Control Study. | Zeng K et al. | โ | 2020 | โ |
| Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function. | Chen J et al. | โ | 2020 | โ |
| Associations between schizophrenia polygenic risk and apathy in schizophrenia spectrum disorders and healthy controls. | Lyngstad SH et al. | โ | 2020 | โ |
| BDNF Serum Levels are Associated With White Matter Microstructure in Schizophrenia - A Pilot Study. | Hammans C et al. | โ | 2020 | โ |
| Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms. | Hsu MC et al. | โ | 2020 | โ |
| Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients. | Garcia-Rosa S et al. | โ | 2020 | โ |
| Brain structural correlates of familial risk for mental illness: a meta-analysis of voxel-based morphometry studies in relatives of patients with psychotic or mood disorders. | Zhang W et al. | โ | 2020 | โ |
| Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia. | Aghamaleki-Sarvestani Z et al. | โ | 2020 | โ |
| Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry. | Bigdeli TB et al. | โ | 2020 | โ |
| CRISPR-based functional evaluation of schizophrenia risk variants. | Rajarajan P et al. | โ | 2020 | โ |
| Dendritic Spine Plasticity: Function and Mechanisms. | Runge K et al. | โ | 2020 | โ |
| Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants. | Kataoka Y et al. | โ | 2020 | โ |
| Dissecting the molecular biology of schizophrenia: A call for emphasising genetic and phenotypic heterogeneity: commentary on Torrey and Yolken (this issue). | Schwab SG | โ | 2020 | โ |
| Effect of ZNF804A gene polymorphism (rs1344706) on the plasticity of the functional coupling between the right dorsolateral prefrontal cortex and the contralateral hippocampal formation. | Zhao W et al. | โ | 2020 | โ |
| Effects of HTR1B 3' region polymorphisms and functional regions on gene expression regulation. | Xia X et al. | โ | 2020 | โ |
| Effort-related decision making in humanized COMT mice: Effects of Val<sup>158</sup>Met polymorphisms and possible implications for negative symptoms in humans. | Yang JH et al. | โ | 2020 | โ |
| Epidemiological Studies of Prenatal and Childhood Infection and Schizophrenia. | Karlsson H et al. | โ | 2020 | โ |
| Examining which factors influence age of onset in males and females with schizophrenia. | Neill E et al. | โ | 2020 | โ |
| Expression of Behavioral Phenotypes in Genetic and Environmental Mouse Models of Schizophrenia. | Sultana R et al. | โ | 2020 | โ |
| Extending schizophrenia diagnostic model to predict schizotypy in first-degree relatives. | Kalmady SV et al. | โ | 2020 | โ |
| Gene Expression in Patient-Derived Neural Progenitors Implicates WNT5A Signaling in the Etiology of Schizophrenia. | Evgrafov OV et al. | โ | 2020 | โ |
| Gene-set Enrichment with Mathematical Biology (GEMB). | Cochran AL et al. | โ | 2020 | โ |
| Genetic polymorphisms of PIP5K2A and course of schizophrenia. | Poltavskaya EG et al. | โ | 2020 | โ |
| Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment. | Fabbri C et al. | โ | 2020 | โ |
| Genetics of schizophrenia (Review). | Trifu SC et al. | โ | 2020 | โ |
| Genome-Wide Search for SNP Interactions in GWAS Data: Algorithm, Feasibility, Replication Using Schizophrenia Datasets. | Lee KY et al. | โ | 2020 | โ |
| Genomic Chaos Begets Psychiatric Disorder. | Dwyer DS | โ | 2020 | โ |
| Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development. | Egerton A et al. | โ | 2020 | โ |
| Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling. | Miranda CC et al. | โ | 2020 | โ |
| Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors. | Ma Y et al. | โ | 2020 | โ |
| Identification of a functional 339 bp <i>Alu</i> insertion polymorphism in the schizophrenia-associated locus at 10q24.32. | Yang ZH et al. | โ | 2020 | โ |
| Identification of a functional SNP rs7304782 at schizophrenia risk locus 12q24.31 and validation of its association with schiz ophrenia in Chinese populations. | Ma C et al. | โ | 2020 | โ |
| Increased burden of ultra-rare structural variants localizing to boundaries of topologically associated domains in schizophrenia. | Halvorsen M et al. | โ | 2020 | โ |
| Integrative In Silico Analysis of Genome-Wide DNA Methylation Profiles in Schizophrenia. | Forero DA et al. | โ | 2020 | โ |
| Interactome overlap between schizophrenia and cognition. | Koch E et al. | โ | 2020 | โ |
| In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia. | Koszลa O et al. | โ | 2020 | โ |
| Isoform-specific roles for AKT in affective behavior, spatial memory, and extinction related to psychiatric disorders. | Wong H et al. | โ | 2020 | โ |
| KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits. | Ren M et al. | โ | 2020 | โ |
| Loss-of-function Mutations of CUL3, a High Confidence Gene for Psychiatric Disorders, Lead to Aberrant Neurodevelopment In Human Induced Pluripotent Stem Cells. | Fischer S et al. | โ | 2020 | โ |
| Machine learning analysis of exome trios to contrast the genomic architecture of autism and schizophrenia. | Sardaar S et al. | โ | 2020 | โ |
| Maternal Bacterial Infection During Pregnancy and Offspring Risk of Psychotic Disorders: Variation by Severity of Infection and Offspring Sex. | Lee YH et al. | โ | 2020 | โ |
| Mental health dished up-the use of iPSC models in neuropsychiatric research. | McNeill RV et al. | โ | 2020 | โ |
| Mental health is biological health: Why tackling "diseases of the mind" is an imperative for biological anthropology in the 21st century. | Syme KL et al. | โ | 2020 | โ |
| Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. | Park S et al. | โ | 2020 | โ |
| Meta-analysis of total and differential white blood cell counts in schizophrenia. | Jackson AJ et al. | โ | 2020 | โ |
| mHealth for schizophrenia spectrum disorders management: A systematic review. | Chivilgina O et al. | โ | 2020 | โ |
| Neurocognitive and neurophysiological endophenotypes in schizophrenia: An overview. | Donati FL et al. | โ | 2020 | โ |
| Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity. | Naujock M et al. | โ | 2020 | โ |
| No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies. | Li XN et al. | โ | 2020 | โ |
| No Evidence for Widespread Positive Selection Signatures in Common Risk Alleles Associated with Schizophrenia. | Yao Y et al. | โ | 2020 | โ |
| Novel Approaches for Identifying the Molecular Background of Schizophrenia. | Golov AK et al. | โ | 2020 | โ |
| Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia. | Rey R et al. | โ | 2020 | โ |
| Overview of schizophrenia research and treatment in Pakistan. | Nawaz R et al. | โ | 2020 | โ |
| Pharmacological enrichment of polygenic risk for precision medicine in complex disorders. | Reay WR et al. | โ | 2020 | โ |
| Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants. | Ohi K et al. | โ | 2020 | โ |
| Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients. | Kirchner SK et al. | โ | 2020 | โ |
| Polygenic risk for schizophrenia and subcortical brain anatomy in the UK Biobank cohort. | Grama S et al. | โ | 2020 | โ |
| Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia. | Ohi K et al. | โ | 2020 | โ |
| Polygenic Risk Scores for Subtyping of Schizophrenia. | Chen J et al. | โ | 2020 | โ |
| Polygenic risk scores: from research tools to clinical instruments. | Lewis CM et al. | โ | 2020 | โ |
| Polygenic risk scores in schizophrenia with clinically significant copy number variants. | Taniguchi S et al. | โ | 2020 | โ |
| Polygenic Risk Scores Shed Light on the Relationship between Schizophrenia and Cognitive Functioning: Review and Meta-Analysis. | Mallet J et al. | โ | 2020 | โ |
| Postzygotic Somatic Mutations in the Human Brain Expand the Threshold-Liability Model of Schizophrenia. | Singh SM et al. | โ | 2020 | โ |
| Predicting response to electroconvulsive therapy combined with antipsychotics in schizophrenia using multi-parametric magnetic resonance imaging. | Gong J et al. | โ | 2020 | โ |
| Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample. | Jansen AG et al. | โ | 2020 | โ |
| Psychosis in Alzheimer's Disease. | Ballard C et al. | โ | 2020 | โ |
| Pyrosequencing analysis of IRS1 methylation levels in schizophrenia with tardive dyskinesia. | Li Y et al. | โ | 2020 | โ |
| Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility. | Nawa Y et al. | โ | 2020 | โ |
| Rare variants and biological pathways identified in treatment-refractory depression. | McClain LL et al. | โ | 2020 | โ |
| Recent advances with 5-HT<sub>3</sub> modulators for neuropsychiatric and gastrointestinal disorders. | Juza R et al. | โ | 2020 | โ |
| Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis. | Li H et al. | โ | 2020 | โ |
| Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids. | He S et al. | โ | 2020 | โ |
| Schizophrenia-An Overview. | McCutcheon RA et al. | โ | 2020 | โ |
| Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. | Zamanpoor M | โ | 2020 | โ |
| Schizophrenia patients and their healthy siblings share decreased prefronto-thalamic connectivity but not increased sensorimotor-thalamic connectivity. | Xi C et al. | โ | 2020 | โ |
| Short-active photoperiod gestation induces psychiatry-relevant behavior in healthy mice but a resiliency to such effects are seen in mice with reduced dopamine transporter expression. | Kwiatkowski MA et al. | โ | 2020 | โ |
| Stem Cells for Improving the Treatment of Neurodevelopmental Disorders. | Donegan JJ et al. | โ | 2020 | โ |
| Structural and functional alterations in the brain gray matter among first-degree relatives of schizophrenia patients: A multimodal meta-analysis of fMRI and VBM studies. | Saarinen AIL et al. | โ | 2020 | โ |
| The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders. | Lee KM et al. | โ | 2020 | โ |
| The connection between microbiome and schizophrenia. | Golofast B et al. | โ | 2020 | โ |
| The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications. | Szeligowski T et al. | โ | 2020 | โ |
| The interaction of histone modification related H3F3B and NSD2 genes increases the susceptibility to schizophrenia in a Chinese population. | Liu W et al. | โ | 2020 | โ |
| The Maudsley environmental risk score for psychosis. | Vassos E et al. | โ | 2020 | โ |
| The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology. | Smeland OB et al. | โ | 2020 | โ |
| The relationship of genetic susceptibilities for psychosis with physiological fluctuation in functional MRI data. | Saarinen A et al. | โ | 2020 | โ |
| The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia. | Roomruangwong C et al. | โ | 2020 | โ |
| The role of altered brain structural connectivity in resilience, vulnerability, and disease expression to schizophrenia. | Wei Q et al. | โ | 2020 | โ |
| The role of norepinephrine in the pathophysiology of schizophrenia. | Mรคki-Marttunen V et al. | โ | 2020 | โ |
| The Role of Zebrafish and Laboratory Rodents in Schizophrenia Research. | Langova V et al. | โ | 2020 | โ |
| Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk. | Anderson KM et al. | โ | 2020 | โ |
| Transcriptome analysis of fibroblasts from schizophrenia patients reveals differential expression of schizophrenia-related genes. | Etemadikhah M et al. | โ | 2020 | โ |
| Understanding the genetics of neuropsychiatric disorders: the potential role of genomic regulatory blocks. | Bareลกiฤ A et al. | โ | 2020 | โ |
| Wnt receptor gene <i>FZD1</i> was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort. | Liu X et al. | โ | 2020 | โ |
| Zebrafish as a tool to study schizophrenia-associated copy number variants. | Campbell PD et al. | โ | 2020 | โ |
| A Case-Control Study of ABCB1, ABCB6, and ABCG1 Polymorphisms and Schizophrenia in a Han Chinese Population. | Ma G et al. | โ | 2019 | โ |
| A Cross-Species Systems Genetics Analysis Links APBB1IP as a Candidate for Schizophrenia and Prepulse Inhibition. | Ashbrook DG et al. | โ | 2019 | โ |
| Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility. | Perez SM et al. | โ | 2019 | โ |
| A framework for linking resting-state chronnectome/genome features in schizophrenia: A pilot study. | Rashid B et al. | โ | 2019 | โ |
| Altered Expression of a Unique Set of Genes Reveals Complex Etiology of Schizophrenia. | Kumar A et al. | โ | 2019 | โ |
| Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients. | Liu Y et al. | โ | 2019 | โ |
| A method for building a genome-connectome bipartite graph model. | Yu Q et al. | โ | 2019 | โ |
| Analysis of differentially methylated regions in great apes and extinct hominids provides support for the evolutionary hypothesis of schizophrenia. | Banerjee N et al. | โ | 2019 | โ |
| Assessing whether the association between rheumatoid arthritis and schizophrenia is bidirectional: A nationwide population-based cohort study. | Chen SF et al. | โ | 2019 | โ |
| Association between NRGN gene polymorphism and resting-state hippocampal functional connectivity in schizophrenia. | Zhang Y et al. | โ | 2019 | โ |
| Association between RELN polymorphisms and schizophrenia in a Han population from Northeast China. | Bai W et al. | โ | 2019 | โ |
| Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study. | Periyasamy S et al. | โ | 2019 | โ |
| Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population. | Merk W et al. | โ | 2019 | โ |
| A systematic review of factors that influence the efficacy of cognitive remediation therapy in schizophrenia. | Reser MP et al. | โ | 2019 | โ |
| Biological and practical implications of genome-wide association study of schizophrenia using Bayesian variable selection. | Rowe B et al. | โ | 2019 | โ |
| Brain Banks Spur New Frontiers in Neuropsychiatric Research and Strategies for Analysis and Validation. | Wang L et al. | โ | 2019 | โ |
| Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. | Alnรฆs D et al. | โ | 2019 | โ |
| CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia: An updated meta-analysis. | Zhu D et al. | โ | 2019 | โ |
| Case Report of Childhood-Onset Psychosis in a Patient with a Known WNT10A Mutation. | Kobza AO et al. | โ | 2019 | โ |
| Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives. | Popovic D et al. | โ | 2019 | โ |
| Common genetic variants have associations with human cortical brain regions and risk of schizophrenia. | Bi X et al. | โ | 2019 | โ |
| Comprehensive functional annotation of susceptibility SNPs prioritized 10 genes for schizophrenia. | Niu HM et al. | โ | 2019 | โ |
| Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. | Balan S et al. | โ | 2019 | โ |
| Developing zebrafish experimental animal models relevant to schizophrenia. | Demin KA et al. | โ | 2019 | โ |
| Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia. | Zhuo C et al. | โ | 2019 | โ |
| Dynamic expression of genes associated with schizophrenia and bipolar disorder across development. | Clifton NE et al. | โ | 2019 | โ |
| Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia. | Shao Z et al. | โ | 2019 | โ |
| Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia. | Trossbach SV et al. | โ | 2019 | โ |
| Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms. | Greenwood TA et al. | โ | 2019 | โ |
| Epigenetics and Common Non Communicable Disease. | Tabatabaiefar MA et al. | โ | 2019 | โ |
| Epigenetics and depressionโฉ. | Penner-Goeke S et al. | โ | 2019 | โ |
| Evidence for cerebello-thalamo-cortical hyperconnectivity as a heritable trait for schizophrenia. | Cao H et al. | โ | 2019 | โ |
| Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease. | Creese B et al. | โ | 2019 | โ |
| Exome sequencing in families with severe mental illness identifies novel and rare variants in genes implicated in Mendelian neuropsychiatric syndromes. | Ganesh S et al. | โ | 2019 | โ |
| Familial abnormalities of endocannabinoid signaling in schizophrenia. | Koethe D et al. | โ | 2019 | โ |
| Functional analyses and effect of DNA methylation on the EGR1 gene in patients with schizophrenia. | Hu TM et al. | โ | 2019 | โ |
| Functional analysis of haplotypes and promoter activity at the 5' region of the human GABRB3 gene and associations with schizophrenia. | Liu Y et al. | โ | 2019 | โ |
| Functional genomics reveal gene regulatory mechanisms underlying schizophrenia risk. | Huo Y et al. | โ | 2019 | โ |
| Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain. | Ohi K et al. | โ | 2019 | โ |
| Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study. | Iwata Y et al. | โ | 2019 | โ |
| GWAS of Behavioral Traits. | Mehta D et al. | โ | 2019 | โ |
| Hair cortisol concentrations as an indicator of potential HPA axis hyperactivation in risk for psychosis. | Sรถder E et al. | โ | 2019 | โ |
| Imaging Genetics Towards a Refined Diagnosis of Schizophrenia. | Jiang W et al. | โ | 2019 | โ |
| Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis. | Chouinard VA et al. | โ | 2019 | โ |
| Intellectual and cognitive profiles in patients affected by schizophrenia. | Bechi M et al. | โ | 2019 | โ |
| Interaction of schizophrenia polygenic risk and cortisol level on pre-adolescent brain structure. | Bolhuis K et al. | โ | 2019 | โ |
| Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia. | Bergen SE et al. | โ | 2019 | โ |
| Machine learning in schizophrenia genomics, a case-control study using 5,090 exomes. | Trakadis YJ et al. | โ | 2019 | โ |
| Mega-analysis of Odds Ratio: A Convergent Method for a Deep Understanding of the Genetic Evidence in Schizophrenia. | Jia P et al. | โ | 2019 | โ |
| Meta-analysis of physical activity and effects of social function and quality of life on the physical activity in patients with schizophrenia. | Ohi K et al. | โ | 2019 | โ |
| Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders. | Kim Y et al. | โ | 2019 | โ |
| Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells. | van Hugte E et al. | โ | 2019 | โ |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability. | Reynolds RH et al. | โ | 2019 | โ |
| Multi-scale analysis of schizophrenia risk genes, brain structure, and clinical symptoms reveals integrative clues for subtyping schizophrenia patients. | Ma L et al. | โ | 2019 | โ |
| No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: A case-control study. | Zhang XC et al. | โ | 2019 | โ |
| No interaction between polygenic scores and childhood trauma in predicting suicide attempt in schizophrenia. | Bani-Fatemi A et al. | โ | 2019 | โ |
| Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder. | Sharma LP et al. | โ | 2019 | โ |
| Oscillations in cortico-basal ganglia circuits: implications for Parkinson's disease and other neurologic and psychiatric conditions. | Halje P et al. | โ | 2019 | โ |
| Personality and the Expression of Symptomatology in Schizophrenia and Bipolar Disorder. | Uroลกeviฤ S et al. | โ | 2019 | โ |
| Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia. | Ni P et al. | โ | 2019 | โ |
| Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample. | Miller AP et al. | โ | 2019 | โ |
| Polygenic risk for psychiatric disorders correlates with executive function in typical development. | Schork AJ et al. | โ | 2019 | โ |
| Polygenic risk for schizophrenia and season of birth within the UK Biobank cohort. | Escott-Price V et al. | โ | 2019 | โ |
| Polygenic risk score increases schizophrenia liability through cognition-relevant pathways. | Toulopoulou T et al. | โ | 2019 | โ |
| Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample. | Kendler KS et al. | โ | 2019 | โ |
| Prefrontal Coexpression of Schizophrenia Risk Genes Is Associated With Treatment Response in Patients. | Pergola G et al. | โ | 2019 | โ |
| Preventing discrimination based on psychiatric risk biomarkers. | Brannan C et al. | โ | 2019 | โ |
| Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes. | Oliver D et al. | โ | 2019 | โ |
| Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. | Chen J et al. | โ | 2019 | โ |
| Shared psychotic disorder in children and young people: a systematic review. | Vigo L et al. | โ | 2019 | โ |
| Smoking Rates and Number of Cigarettes Smoked per Day in Schizophrenia: A Large Cohort Meta-Analysis in a Japanese Population. | Ohi K et al. | โ | 2019 | โ |
| SNAP-25 in Major Psychiatric Disorders: A Review. | Najera K et al. | โ | 2019 | โ |
| The genetics of neuropsychiatric disorders. | Bray NJ et al. | โ | 2019 | โ |
| The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank. | Escott-Price V et al. | โ | 2019 | โ |
| The schizophrenia and bipolar twin study in Sweden (STAR). | Johansson V et al. | โ | 2019 | โ |
| Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. | Lee CH et al. | โ | 2019 | โ |
| Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. | Prata DP et al. | โ | 2019 | โ |
| Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome | Forghani I | โ | 2019 | โ |
| Use of the epigenetic toolboxโจto contextualize common variants associated with schizophrenia riskโฉ. | Rajarajan P et al. | โ | 2019 | โ |
| Zebrafish as an Emerging Model for Bioassay-Guided Natural Product Drug Discovery for Neurological Disorders. | Pitchai A et al. | โ | 2019 | โ |
| A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia. | Gonรงalves VF et al. | โ | 2018 | โ |
| A Family Study of the <i>DSM-5</i> Section III Personality Pathology Model Using the Personality Inventory for the <i>DSM-5</i> (PID-5). | Katz AC et al. | โ | 2018 | โ |
| A genome-wide association study of early gamma-band response in a schizophrenia case-control sample. | Konte B et al. | โ | 2018 | โ |
| Alteration of gray matter microstructure in schizophrenia. | Seitz J et al. | โ | 2018 | โ |
| Analysis of Gene Expression Variance in Schizophrenia Using Structural Equation Modeling. | Igolkina AA et al. | โ | 2018 | โ |
| Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach. | Hu Y et al. | โ | 2018 | โ |
| A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme. | Magri C et al. | โ | 2018 | โ |
| A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia. | Liu J et al. | โ | 2018 | โ |
| A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. | Ranlund S et al. | โ | 2018 | โ |
| Are Schemas Passed on? A Study on the Association Between Early Maladaptive Schemas in Parents and Their Offspring and the Putative Translating Mechanisms. | Sundag J et al. | โ | 2018 | โ |
| Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia. | McCarthy NS et al. | โ | 2018 | โ |
| Association between CMYA5 gene polymorphisms and risk of schizophrenia in Uygur population and a meta-analysis. | Han S et al. | โ | 2018 | โ |
| Association of copy number variation across the genome with neuropsychiatric traits in the general population. | Guyatt AL et al. | โ | 2018 | โ |
| Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. | Blakey R et al. | โ | 2018 | โ |
| A systematic review of genome-wide research on psychotic experiences and negative symptom traits: new revelations and implications for psychiatry. | Ronald A et al. | โ | 2018 | โ |
| Autoimmune diseases are associated with an increased risk of schizophrenia: A nationwide population-based cohort study. | Wang LY et al. | โ | 2018 | โ |
| Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophrenia. | Scarr E et al. | โ | 2018 | โ |
| Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells. | Hoffmann A et al. | โ | 2018 | โ |
| Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study. | Cheng CM et al. | โ | 2018 | โ |
| Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans. | Allswede DM et al. | โ | 2018 | โ |
| Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes. | Yang CP et al. | โ | 2018 | โ |
| Copy Number Variant in the Region of Adenosine Kinase (ADK) and Its Possible Contribution to Schizophrenia Susceptibility. | Kimura H et al. | โ | 2018 | โ |
| Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia. | Lin D et al. | โ | 2018 | โ |
| Dimensional Traits of Schizotypy Associated With Glycine Receptor GLRA1 Polymorphism: An Exploratory Candidate-Gene Association Study. | Vora AK et al. | โ | 2018 | โ |
| Discovery biology of neuropsychiatric syndromes (DBNS): a center for integrating clinical medicine and basic science. | Viswanath B et al. | โ | 2018 | โ |
| Effect of rs1344706 in the <i>ZNF804A</i> gene on the brain network. | Chen X et al. | โ | 2018 | โ |
| Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. | Bryois J et al. | โ | 2018 | โ |
| Exome Sequencing Identifies <i>TENM4</i> as a Novel Candidate Gene for Schizophrenia in the SCZD2 Locus at 11q14-21. | Xue CB et al. | โ | 2018 | โ |
| Exploration and characterisation of the phenotypic and genetic profiles of patients with early onset schizophrenia associated with autism spectrum disorder and their first-degree relatives: a French multicentre case series study protocol (GenAuDiss). | Fernandez A et al. | โ | 2018 | โ |
| Expression-based drug screening of neural progenitor cells from individuals with schizophrenia. | Readhead B et al. | โ | 2018 | โ |
| Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases. | Sundararajan T et al. | โ | 2018 | โ |
| Further evidence for the genetic association between <i>CACNA1I</i> and schizophrenia. | Xie Y et al. | โ | 2018 | โ |
| GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation. | Jiang DY et al. | โ | 2018 | โ |
| Gabrb2-knockout mice displayed schizophrenia-like and comorbid phenotypes with interneuron-astrocyte-microglia dysregulation. | Yeung RK et al. | โ | 2018 | โ |
| Gene-environment interaction and psychiatric disorders: Review and future directions. | Assary E et al. | โ | 2018 | โ |
| Gene-environment interplay in the etiology of psychosis. | Zwicker A et al. | โ | 2018 | โ |
| Genetic association and meta-analysis of a schizophrenia GWAS variant rs10489202 in East Asian populations. | Yang Y et al. | โ | 2018 | โ |
| Genetic Association of the Norepinephrine Transporter Gene G1287A Polymorphism with Risk of Schizophrenia: A Case-Control Study and Meta-Analysis. | Zhao X et al. | โ | 2018 | โ |
| Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs. | Ohi K et al. | โ | 2018 | โ |
| Genetic risk scores and family history as predictors of schizophrenia in Nordic registers. | Lu Y et al. | โ | 2018 | โ |
| Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review. | Soler J et al. | โ | 2018 | โ |
| Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features. | Calabrรฒ M et al. | โ | 2018 | โ |
| Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. | Hiemstra M et al. | โ | 2018 | โ |
| Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia. | Bansal V et al. | โ | 2018 | โ |
| Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register. | Hilker R et al. | โ | 2018 | โ |
| Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role. | Porcelli S et al. | โ | 2018 | โ |
| Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia. | Ma J et al. | โ | 2018 | โ |
| Identification of shared genetic variants between schizophrenia and lung cancer. | Zuber V et al. | โ | 2018 | โ |
| Imaging and Genetic Biomarkers Predicting Transition to Psychosis. | Hunter SA et al. | โ | 2018 | โ |
| Imaging genetics of schizophrenia in the post-GWAS era. | Arslan A | โ | 2018 | โ |
| Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia. | Okazaki S et al. | โ | 2018 | โ |
| Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia. | Narla ST et al. | โ | 2018 | โ |
| Interaction between BDNF and TNF-ฮฑ genes in schizophrenia. | Zhang Y et al. | โ | 2018 | โ |
| Interaction between compound genetic risk for schizophrenia and high birth weight contributes to social anhedonia and schizophrenia in women. | Liuhanen J et al. | โ | 2018 | โ |
| Investigation of chromosome Y loss in men with schizophrenia. | Hirata T et al. | โ | 2018 | โ |
| <i>VRK2</i>, a Candidate Gene for Psychiatric and Neurological Disorders. | Li M et al. | โ | 2018 | โ |
| Leukocyte telomere length variation in different stages of schizophrenia. | Maurya PK et al. | โ | 2018 | โ |
| Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression. | Wang AK et al. | โ | 2018 | โ |
| Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium. | Zhang T et al. | โ | 2018 | โ |
| microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease. | Thomas KT et al. | โ | 2018 | โ |
| Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia. | Zheutlin AB et al. | โ | 2018 | โ |
| Neural Mechanisms of Early-Life Social Stress as a Developmental Risk Factor for Severe Psychiatric Disorders. | Reinwald JR et al. | โ | 2018 | โ |
| No association between FOXP2 rs10447760 and schizophrenia in a replication study of the Chinese Han population. | Yin J et al. | โ | 2018 | โ |
| On variability & human consciousness. | Boutwell BB | โ | 2018 | โ |
| Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder. | Jepsen JRM et al. | โ | 2018 | โ |
| Polygenic risk for schizophrenia affects working memory and its neural correlates in healthy subjects. | Krug A et al. | โ | 2018 | โ |
| Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. | Shafee R et al. | โ | 2018 | โ |
| Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort. | Santoro ML et al. | โ | 2018 | โ |
| Polygenic signal for symptom dimensions and cognitive performance in patients with chronic schizophrenia. | Xavier RM et al. | โ | 2018 | โ |
| Polymorphism in schizophrenia risk gene <i>MIR137</i> is associated with the posterior cingulate Cortex's activation and functional and structural connectivity in healthy controls. | Zhang Z et al. | โ | 2018 | โ |
| Polymorphisms in the human serotonin receptor 1B (HTR1B) gene are associated with schizophrenia: a case control study. | Xia X et al. | โ | 2018 | โ |
| Post-GWAS in Psychiatric Genetics: A Developmental Perspective on the "Other" Next Steps. | Dick DM et al. | โ | 2018 | โ |
| Proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia susceptibility: a meta-analysis. | Guo X et al. | โ | 2018 | โ |
| Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review. | Orsolini L et al. | โ | 2018 | โ |
| Psychiatric Genomics: An Update and an Agenda. | Sullivan PF et al. | โ | 2018 | โ |
| Quantitative DNA Methylation Analysis of DLGAP2 Gene using Pyrosequencing in Schizophrenia with Tardive Dyskinesia: A Linear Mixed Model Approach. | Li Y et al. | โ | 2018 | โ |
| Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility. | Yu Y et al. | โ | 2018 | โ |
| Recently evolved human-specific methylated regionsย are enriched in schizophrenia signals. | Banerjee N et al. | โ | 2018 | โ |
| Rigor and reproducibility in genetic research on eating disorders. | Hรผbel C et al. | โ | 2018 | โ |
| Should we be targeting sleep architecture to more effectively treat schizophrenia? | Luu B et al. | โ | 2018 | โ |
| Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy. | Iversen TSJ et al. | โ | 2018 | โ |
| Thalamic Reticular Dysfunction as a Circuit Endophenotype in Neurodevelopmental Disorders. | Krol A et al. | โ | 2018 | โ |
| The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review. | Fontana BD et al. | โ | 2018 | โ |
| The GABRB3 Polymorphism and its Association with Schizophrenia. | Liu Y et al. | โ | 2018 | โ |
| The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. | Blokland GAM et al. | โ | 2018 | โ |
| The <i>DGCR5</i> long noncoding RNA may regulate expression of several schizophrenia-related genes. | Meng Q et al. | โ | 2018 | โ |
| The integrated landscape of causal genes and pathways in schizophrenia. | Ma C et al. | โ | 2018 | โ |
| The relationship between fine particulate matter (PM<sub>2.5</sub>) and schizophrenia severity. | Eguchi R et al. | โ | 2018 | โ |
| The role of cadherin genes in five major psychiatric disorders: A literature update. | Hawi Z et al. | โ | 2018 | โ |
| The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review. | Mistry S et al. | โ | 2018 | โ |
| Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells. | Ahmad R et al. | โ | 2018 | โ |
| Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism. | St Clair D et al. | โ | 2018 | โ |
| Whole genome sequencing of 91 multiplex schizophrenia families reveals increased burden of rare, exonic copy number variation in schizophrenia probands and genetic heterogeneity. | Khan FF et al. | โ | 2018 | โ |
| ZNF804A Variation May Affect Hippocampal-Prefrontal Resting-State Functional Connectivity in Schizophrenic and Healthy Individuals. | Zhang Y et al. | โ | 2018 | โ |
| Aberrant perfusion and its connectivity within default mode network of first-episode drug-naรฏve schizophrenia patients and their unaffected first-degree relatives. | Cui LB et al. | โ | 2017 | โ |
| Abnormal Rich-Club Organization Associated with Compromised Cognitive Function in Patients with Schizophrenia and Their Unaffected Parents. | Zhao X et al. | โ | 2017 | โ |
| A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient. | Ohi K et al. | โ | 2017 | โ |
| Accumulation of minor alleles and risk prediction in schizophrenia. | He P et al. | โ | 2017 | โ |
| ALDH2 Glu504Lys Confers Susceptibility to Schizophrenia and Impacts Hippocampal-Prefrontal Functional Connectivity. | Zheng F et al. | โ | 2017 | โ |
| Altered DLPFC-Hippocampus Connectivity During Working Memory: Independent Replication and Disorder Specificity of a Putative Genetic Risk Phenotype for Schizophrenia. | Schneider M et al. | โ | 2017 | โ |
| A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility. | Kimura H et al. | โ | 2017 | โ |
| A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans. | Rampino A et al. | โ | 2017 | โ |
| Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia. | Liu YN et al. | โ | 2017 | โ |
| A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia. | D'Addario C et al. | โ | 2017 | โ |
| Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence. | Sauerzopf U et al. | โ | 2017 | โ |
| A Review of the Functional and Anatomical Default Mode Network in Schizophrenia. | Hu ML et al. | โ | 2017 | โ |
| Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia: A meta-analysis of case-control studies. | Feng Y et al. | โ | 2017 | โ |
| Association of transcription factor 4 (TCF4) gene mRNA level with schizophrenia, its psychopathology, intelligence and cognitive impairments. | Alizadeh F et al. | โ | 2017 | โ |
| Basal ganglia and ventricle volume in first-episode psychosis. A family and clinical study. | Cuesta MJ et al. | โ | 2017 | โ |
| Challenges and opportunities for the development of new antipsychotic drugs. | Forray C et al. | โ | 2017 | โ |
| Chronic mild stress impairs latent inhibition and induces region-specific neural activation in CHL1-deficient mice, a mouse model of schizophrenia. | Buhusi M et al. | โ | 2017 | โ |
| Ciproxifan, a histamine H<sub>3</sub> receptor antagonist and inverse agonist, presynaptically inhibits glutamate release in rat hippocampus. | Lu CW et al. | โ | 2017 | โ |
| Cognitive clustering in schizophrenia patients, their first-degree relatives and healthy subjects is associated with anterior cingulate cortex volume. | Ohi K et al. | โ | 2017 | โ |
| Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS). | Narla ST et al. | โ | 2017 | โ |
| Cross Talk: The Microbiota and Neurodevelopmental Disorders. | Kelly JR et al. | โ | 2017 | โ |
| De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity. | Nishi A et al. | โ | 2017 | โ |
| Differences in social functioning among patients with major psychiatric disorders: Interpersonal communication is impaired in patients with schizophrenia and correlates with an increase in schizotypal traits. | Yasuyama T et al. | โ | 2017 | โ |
| Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis. | Williams DR et al. | โ | 2017 | โ |
| Electroconvulsive therapy-induced brain functional connectivity predicts therapeutic efficacy in patients with schizophrenia: a multivariate pattern recognition study. | Li P et al. | โ | 2017 | โ |
| Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides. | Hoffmann A et al. | โ | 2017 | โ |
| Evaluation of European Schizophrenia GWAS Loci in Asian Populations via Comprehensive Meta-Analyses. | Xiao X et al. | โ | 2017 | โ |
| Exome array analysis suggests an increased variant burden in families with schizophrenia. | McCarthy NS et al. | โ | 2017 | โ |
| Exome sequences of multiplex, multigenerational families reveal schizophrenia risk loci with potential implications for neurocognitive performance. | Kos MZ et al. | โ | 2017 | โ |
| Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist. | Martin J et al. | โ | 2017 | โ |
| Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits. | So HC et al. | โ | 2017 | โ |
| Familial Aggregation and Heritability of Schizophrenia and Co-aggregation of Psychiatric Illnesses in Affected Families. | Chou IJ et al. | โ | 2017 | โ |
| Familial and environmental influences on brain volumes in twins with schizophrenia. | Picchioni MM et al. | โ | 2017 | โ |
| Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity. | Kim MJ et al. | โ | 2017 | โ |
| Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains. | Erk S et al. | โ | 2017 | โ |
| Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins. | Nesvรฅg R et al. | โ | 2017 | โ |
| Genetic and Environmental Influences on Gambling: A Meta-Analysis of Twin Studies. | Xuan YH et al. | โ | 2017 | โ |
| Genetic Approaches to Understanding Psychiatric Disease. | Michaelson JJ | โ | 2017 | โ |
| Genetic Basis of Positive and Negative Symptom Domains in Schizophrenia. | Xavier RM et al. | โ | 2017 | โ |
| Genetic insights into the neurodevelopmental origins of schizophrenia. | Birnbaum R et al. | โ | 2017 | โ |
| Genetic loci associated with an earlier age at onset in multiplex schizophrenia. | Woolston AL et al. | โ | 2017 | โ |
| Genetic Overlap Between Schizophrenia and Developmental Psychopathology: Longitudinal and Multivariate Polygenic Risk Prediction of Common Psychiatric Traits During Development. | Nivard MG et al. | โ | 2017 | โ |
| Genetics of Depression: Progress at Last. | Mullins N et al. | โ | 2017 | โ |
| Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics. | Giegling I et al. | โ | 2017 | โ |
| Genetics of Schizophrenia: Overview of Methods, Findings and Limitations. | Henriksen MG et al. | โ | 2017 | โ |
| Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor. | Bลasiak E et al. | โ | 2017 | โ |
| GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients. | Pinheiro DS et al. | โ | 2017 | โ |
| Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia. | Nkam I et al. | โ | 2017 | โ |
| Impact of Familial Loading on Prefrontal Activation in Major Psychiatric Disorders: A Near-Infrared Spectroscopy (NIRS) Study. | Ohi K et al. | โ | 2017 | โ |
| Influence of <i>CFH</i> gene on symptom severity of schizophrenia. | Zhang C et al. | โ | 2017 | โ |
| Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders. | Nguyen HT et al. | โ | 2017 | โ |
| INTERNEURONOPATHIES AND THEIR ROLE IN EARLY LIFE EPILEPSIES AND NEURODEVELOPMENTAL DISORDERS. | Katsarou AM et al. | โ | 2017 | โ |
| Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis. | Bรผrkner PC et al. | โ | 2017 | โ |
| Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection. | Katsel P et al. | โ | 2017 | โ |
| Modeling a linkage between blood transcriptional expression and activity in brain regions to infer the phenotype of schizophrenia patients. | Ibrahim EC et al. | โ | 2017 | โ |
| Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs). | Noh H et al. | โ | 2017 | โ |
| Modelling gene-environment interaction in first episodes of psychosis. | Bernardo M et al. | โ | 2017 | โ |
| Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies. | Xiao X et al. | โ | 2017 | โ |
| mtDNA Heteroplasmy in Monozygotic Twins Discordant for Schizophrenia. | Li H et al. | โ | 2017 | โ |
| Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia. | Leonenko G et al. | โ | 2017 | โ |
| Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry. | Mulligan KA et al. | โ | 2017 | โ |
| No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis. | Qi XL et al. | โ | 2017 | โ |
| No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes. | Johnson EC et al. | โ | 2017 | โ |
| Personalized medicine in psychiatry. | Wium-Andersen IK et al. | โ | 2017 | โ |
| Pluripotent stem cells in neuropsychiatric disorders. | Soliman MA et al. | โ | 2017 | โ |
| Polygenic risk has an impact on the structural plasticity of hippocampal subfields during aerobic exercise combined with cognitive remediation in multi-episode schizophrenia. | Papiol S et al. | โ | 2017 | โ |
| Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia. | John J et al. | โ | 2017 | โ |
| Predicting Cognitive Executive Functioning with Polygenic Risk Scores for Psychiatric Disorders. | Benca CE et al. | โ | 2017 | โ |
| Predictors of change in social networks, support and satisfaction following a first episode psychosis: A cohort study. | Renwick L et al. | โ | 2017 | โ |
| Probing the Association between Early Evolutionary Markers and Schizophrenia. | Srinivasan S et al. | โ | 2017 | โ |
| Progress in genome-wide association studies of schizophrenia in Han Chinese populations. | Yue W et al. | โ | 2017 | โ |
| Psychiatric disorders biochemical pathways unraveled by human brain proteomics. | Saia-Cereda VM et al. | โ | 2017 | โ |
| QKI6B mRNA levels are upregulated in schizophrenia and predict GFAP expression. | Farnsworth B et al. | โ | 2017 | โ |
| Replicated association between the European GWAS locus rs10503253 at CSMD1 and schizophrenia in Asian population. | Liu W et al. | โ | 2017 | โ |
| Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders. | Lamanna AL et al. | โ | 2017 | โ |
| Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder. | Fabbri C et al. | โ | 2017 | โ |
| Role of CACNA1C gene polymorphisms and protein expressions in the pathogenesis of schizophrenia: a case-control study in a Chinese population. | Zhang SY et al. | โ | 2017 | โ |
| Schizophrenia: What's Arc Got to Do with It? | Managรฒ F et al. | โ | 2017 | โ |
| [Search for risk genes in schizophrenia]. | Rujescu D | โ | 2017 | โ |
| Short communication: Genetic association between schizophrenia and cannabis use. | Verweij KJ et al. | โ | 2017 | โ |
| Small non-coding RNA expression from anterior cingulate cortex in schizophrenia shows sex specific regulation. | Ragan C et al. | โ | 2017 | โ |
| Synaptic activity: An emerging player in schizophrenia. | Sarkar A et al. | โ | 2017 | โ |
| SZDB: A Database for Schizophrenia Genetic Research. | Wu Y et al. | โ | 2017 | โ |
| Testing the psychological pain hypothesis for postnatal depression: Reproductive success versus evidence of design. | Hagen EH et al. | โ | 2017 | โ |
| The Anorexia Nervosa Genetics Initiative: Study description and sample characteristics of the Australian and New Zealand arm. | Kirk KM et al. | โ | 2017 | โ |
| The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies. | Harari JH et al. | โ | 2017 | โ |
| The kynurenine pathway in schizophrenia and bipolar disorder. | Erhardt S et al. | โ | 2017 | โ |
| The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions. | Chang H et al. | โ | 2017 | โ |
| Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms. | Flaherty EK et al. | โ | 2017 | โ |
| Variability of 128 schizophrenia-associated gene variants across distinct ethnic populations. | Ohi K et al. | โ | 2017 | โ |
| VarScan2 analysis of de novo variants in monozygotic twins discordant for schizophrenia. | Reble E et al. | โ | 2017 | โ |
| Whole-genome sequencing of monozygotic twins discordant for schizophrenia indicates multiple genetic risk factors for schizophrenia. | Tang J et al. | โ | 2017 | โ |
| A cis-eQTL in AHI1 confers risk to schizophrenia in European populations. | Ren Z et al. | โ | 2016 | โ |
| A common NTRK2 variant is associated with emotional arousal and brain white-matter integrity in healthy young subjects. | Spalek K et al. | โ | 2016 | โ |
| A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium | Marshall CR et al. | โ | 2016 | โ |
| A current snapshot of common genomic variants contribution in psychiatric disorders. | Santoro ML et al. | โ | 2016 | โ |
| A Danish Twin Study of Schizophrenia Liability: Investigation from Interviewed Twins for Genetic Links to Affective Psychoses and for Cross-Cohort Comparisons. | Klรคning U et al. | โ | 2016 | โ |
| A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research. | Kรกlmรกn S et al. | โ | 2016 | โ |
| A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. | Goldsmith DR et al. | โ | 2016 | โ |
| A meta-analysis of FZD3 gene polymorphisms and their association with schizophrenia. | Pantavou KG et al. | โ | 2016 | โ |
| AMIGO-Kv2.1 Potassium Channel Complex Is Associated With Schizophrenia-Related Phenotypes. | Peltola MA et al. | โ | 2016 | โ |
| An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia. | Yan P et al. | โ | 2016 | โ |
| A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity. | Huang T et al. | โ | 2016 | โ |
| Animal Models of Maternal Immune Activation in Depression Research. | Ronovsky M et al. | โ | 2016 | โ |
| Anterior Cingulate Cortico-Hippocampal Dysconnectivity in Unaffected Relatives of Schizophrenia Patients: A Stochastic Dynamic Causal Modeling Study. | Xi YB et al. | โ | 2016 | โ |
| A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder. | Chen J et al. | โ | 2016 | โ |
| A significant causal association between C-reactive protein levels and schizophrenia. | Inoshita M et al. | โ | 2016 | โ |
| A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. | Cohen OS et al. | โ | 2016 | โ |
| Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. | Gassรณ P et al. | โ | 2016 | โ |
| Association of Dystrobrevin-Binding Protein 1 Polymorphisms with Sustained Attention and Set-Shifting in Schizophrenia Patients. | Bakanidze G et al. | โ | 2016 | โ |
| Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies. | Feng Y et al. | โ | 2016 | โ |
| Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders. | Mezquida G et al. | โ | 2016 | โ |
| Association of the DISC1 and NRG1 genetic polymorphisms with schizophrenia in a Chinese population. | He BS et al. | โ | 2016 | โ |
| A study of single nucleotide polymorphisms of GRIN2B in schizophrenia from Chinese Han population. | Guo Z et al. | โ | 2016 | โ |
| A study of type-1 diabetes associated autoantibodies in schizophrenia. | Hallford P et al. | โ | 2016 | โ |
| Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. | Lai CY et al. | โ | 2016 | โ |
| Brains, genes and power. | Albert FW | โ | 2016 | โ |
| Can Psychological, Social and Demographical Factors Predict Clinical Characteristics Symptomatology of Bipolar Affective Disorder and Schizophrenia? | Maciukiewicz M et al. | โ | 2016 | โ |
| Common variants in the chromosome 2p23 region containing the SLC30A3 (ZnT3) gene are associated with schizophrenia in female but not male individuals in a large collection of European samples. | Perez-Becerril C et al. | โ | 2016 | โ |
| Common variants on 17q25 and gene-gene interactions conferring risk of schizophrenia in Han Chinese population and regulating gene expressions in human brain. | Guan L et al. | โ | 2016 | โ |
| Concerns about Genetic Testing for Schizophrenia among Young Adults at Clinical High Risk for Psychosis. | Lawrence RE et al. | โ | 2016 | โ |
| Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics. | Schmitt A et al. | โ | 2016 | โ |
| Contrasting the Genetic Architecture of 30 Complex Traits from Summary Association Data. | Shi H et al. | โ | 2016 | โ |
| Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. | Borg J et al. | โ | 2016 | โ |
| Covariance Association Test (CVAT) Identifies Genetic Markers Associated with Schizophrenia in Functionally Associated Biological Processes. | Rohde PD et al. | โ | 2016 | โ |
| Current evolutionary adaptiveness of psychiatric disorders: Fertility rates, parent-child relationship quality, and psychiatric disorders across the lifespan. | Jacobson NC | โ | 2016 | โ |
| Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naรฏve First Episode Psychosis. | Noto C et al. | โ | 2016 | โ |
| DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond. | Markkanen E et al. | โ | 2016 | โ |
| Effect of rs1063843 in the CAMKK2 gene on the dorsolateral prefrontal cortex. | Yu P et al. | โ | 2016 | โ |
| Estimating Effect Sizes and Expected Replication Probabilities from GWAS Summary Statistics. | Holland D et al. | โ | 2016 | โ |
| Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study. | Edwards AC et al. | โ | 2016 | โ |
| Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function. | Guan F et al. | โ | 2016 | โ |
| Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies. | Harvey PD et al. | โ | 2016 | โ |
| Familial covariation of facial emotion recognition and IQ in schizophrenia. | Andric S et al. | โ | 2016 | โ |
| Familiality of Psychotic Disorders: A Polynosologic Study in Multiplex Families. | Peralta V et al. | โ | 2016 | โ |
| Functional Characterization of Schizophrenia-Associated Variation in CACNA1C. | Eckart N et al. | โ | 2016 | โ |
| Functional connectivity measures as schizophrenia intermediate phenotypes: advances, limitations, and future directions. | Cao H et al. | โ | 2016 | โ |
| Further evidence of VRK2 rs2312147 associated with schizophrenia. | Chang H et al. | โ | 2016 | โ |
| Gendering psychosis: the illness of Zelda Fitzgerald. | Seeman MV | โ | 2016 | โ |
| Gene ร Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models. | Moran P et al. | โ | 2016 | โ |
| Genetic and Environmental Contribution to Major Depressive Disorder and Self-declared Depression. | Fabbri C | โ | 2016 | โ |
| Genetic association of GWAS-supported MAD1L1 gene polymorphism rs12666575 with schizophrenia susceptibility in a Chinese population. | Su L et al. | โ | 2016 | โ |
| Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. | Managรฒ F et al. | โ | 2016 | โ |
| Genetic Evaluation of Schizophrenia Using the Illumina HumanExome Chip. | Moons T et al. | โ | 2016 | โ |
| Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure. | Bohlken MM et al. | โ | 2016 | โ |
| Genome-Wide Association Studies Suggest Limited Immune Gene Enrichment in Schizophrenia Compared to 5 Autoimmune Diseases. | Pouget JG et al. | โ | 2016 | โ |
| Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness. | Bigdeli TB et al. | โ | 2016 | โ |
| Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity. | Gadelha A et al. | โ | 2016 | โ |
| GWAS-identified schizophrenia risk SNPs at TSPAN18 are highly diverged between Europeans and East Asians. | Liu J et al. | โ | 2016 | โ |
| Heritability of autism spectrum disorders: a meta-analysis of twin studies. | Tick B et al. | โ | 2016 | โ |
| Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia. | Hedman AM et al. | โ | 2016 | โ |
| Hopes and Expectations Regarding Genetic Testing for Schizophrenia Among Young Adults at Clinical High-Risk for Psychosis. | Friesen P et al. | โ | 2016 | โ |
| Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. | Hyde CL et al. | โ | 2016 | โ |
| Identification of rare variants in KCTD13 at the schizophrenia risk locus 16p11.2. | Degenhardt F et al. | โ | 2016 | โ |
| Identification of RELN variation p.Thr3192Ser in a Chinese family with schizophrenia. | Zhou Z et al. | โ | 2016 | โ |
| Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis. | Harrisberger F et al. | โ | 2016 | โ |
| Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. | Genovese G et al. | โ | 2016 | โ |
| Increased GABA<sub>B</sub> receptor signaling in a rat model for schizophrenia. | Selten MM et al. | โ | 2016 | โ |
| Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder. | Jรธrgensen KN et al. | โ | 2016 | โ |
| Integrated Post-GWAS Analysis Sheds New Light on the Disease Mechanisms of Schizophrenia. | Lin JR et al. | โ | 2016 | โ |
| Interaction between DISC1 and CHL1 in regulation of neurite outgrowth. | Ren J et al. | โ | 2016 | โ |
| Lack of Association Between Dopamine Beta-Hydroxylase (DBH) 19-bp Insertion/Deletion Polymorphism and Risk of Schizophrenia. | Shakiba M et al. | โ | 2016 | โ |
| Leveraging Genomic Annotations and Pleiotropic Enrichment for Improved Replication Rates in Schizophrenia GWAS. | Wang Y et al. | โ | 2016 | โ |
| Maladaptive interpersonal schemas as sensitive and specific markers of borderline personality disorder among psychiatric inpatients. | Cohen LJ et al. | โ | 2016 | โ |
| Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. | Edwards AC et al. | โ | 2016 | โ |
| MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients. | Wu S et al. | โ | 2016 | โ |
| Modeling psychiatric disorders: from genomic findings to cellular phenotypes. | Falk A et al. | โ | 2016 | โ |
| Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons. | Habela CW et al. | โ | 2016 | โ |
| Molecular Risk Factors for Schizophrenia. | Modai S et al. | โ | 2016 | โ |
| Molecular subtyping and improved treatment of neurodevelopmental disease. | Stessman HA et al. | โ | 2016 | โ |
| Neuroimaging Intermediate Phenotypes of Executive Control Dysfunction in Schizophrenia. | Sutcliffe G et al. | โ | 2016 | โ |
| No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population. | Liu Y et al. | โ | 2016 | โ |
| Offspring of Parents with Schizophrenia: A Systematic Review of Developmental Features Across Childhood. | Hameed MA et al. | โ | 2016 | โ |
| Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophrenia. | Lee PH et al. | โ | 2016 | โ |
| Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function. | Schwarz E et al. | โ | 2016 | โ |
| Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology. | Cox DA et al. | โ | 2016 | โ |
| Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. | Singh T et al. | โ | 2016 | โ |
| Rare mutations and hypermethylation of the ARC gene associated with schizophrenia. | Chuang YA et al. | โ | 2016 | โ |
| Rare variants are common in schizophrenia. | Gratten J | โ | 2016 | โ |
| Recent Positive Selection Drives the Expansion of a Schizophrenia Risk Nonsynonymous Variant at SLC39A8 in Europeans. | Li M et al. | โ | 2016 | โ |
| Reduced cardiac autonomic response to deep breathing: A heritable vulnerability trait in patients with schizophrenia and their healthy first-degree relatives. | Liu YW et al. | โ | 2016 | โ |
| Relationship between phosphoinositide-3-kinase genetic polymorphism and schizophrenia. | Kordi-Tamandani DM et al. | โ | 2016 | โ |
| Replication analyses of four chromosomal deletions with schizophrenia via independent large-scale meta-analyses. | Chang H et al. | โ | 2016 | โ |
| Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders. | Xing J et al. | โ | 2016 | โ |
| Risk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations. | Gratten J et al. | โ | 2016 | โ |
| Schizophrenia. | Owen MJ et al. | โ | 2016 | โ |
| Schizophrenia in the Era of Brain Complexity. | Collin G et al. | โ | 2016 | โ |
| Seeking an objective diagnosis of depression. | Bilello JA | โ | 2016 | โ |
| Stratifying empiric risk of schizophrenia among first degree relatives using multiple predictors in two independent Indian samples. | Bhatia T et al. | โ | 2016 | โ |
| Study of the tetraspanin 18 association with schizophrenia in a Han Chinese population. | Wu L et al. | โ | 2016 | โ |
| Targeting the Endocannabinoid System in Psychiatric Illness. | Katzman MA et al. | โ | 2016 | โ |
| The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations. | Wang Y et al. | โ | 2016 | โ |
| The Broad Autism (Endo)Phenotype: Neurostructural and Neurofunctional Correlates in Parents of Individuals with Autism Spectrum Disorders. | Billeci L et al. | โ | 2016 | โ |
| The Future is The Past: Methylation QTLs in Schizophrenia. | Hoffmann A et al. | โ | 2016 | โ |
| The known and missing links between Toxoplasma gondii and schizophrenia. | Elsheikha HM et al. | โ | 2016 | โ |
| The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders. | van de Leemput J et al. | โ | 2016 | โ |
| The role of Pannexin gene variants in schizophrenia: systematic analysis of phenotypes. | Gawlik M et al. | โ | 2016 | โ |
| Top 10 Replicated Findings From Behavioral Genetics. | Plomin R et al. | โ | 2016 | โ |
| Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders. | Lin M et al. | โ | 2016 | โ |
| Two-stage additional evidence support association of common variants in the HDAC3 with the increasing risk of schizophrenia susceptibility. | Jia X et al. | โ | 2016 | โ |
| Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population. | Guan F et al. | โ | 2016 | โ |
| Variants in TERT influencing telomere length are associated with paranoid schizophrenia risk. | Rao S et al. | โ | 2016 | โ |
| Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis. | Chang M et al. | โ | 2016 | โ |
| VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls. | Tesli M et al. | โ | 2016 | โ |
| Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness. | Homann OR et al. | โ | 2016 | โ |
| ฮ-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review. | Chung JK et al. | โ | 2016 | โ |
| Aberrant Cortical Morphometry in the 22q11.2 Deletion Syndrome. | Schmitt JE et al. | โ | 2015 | โ |
| Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. | Sun XY et al. | โ | 2015 | โ |
| Abnormal immune system development and function in schizophrenia helps reconcile diverse findings and suggests new treatment and prevention strategies. | Anders S et al. | โ | 2015 | โ |
| Additive genetic risk from five serotonin system polymorphisms interacts with interpersonal stress to predict depression. | Vrshek-Schallhorn S et al. | โ | 2015 | โ |
| Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients. | Yu HC et al. | โ | 2015 | โ |
| An Empirical Bayes Mixture Model for Effect Size Distributions in Genome-Wide Association Studies. | Thompson WK et al. | โ | 2015 | โ |
| An interaction between NDE1 and high birth weight increases schizophrenia susceptibility. | Wegelius A et al. | โ | 2015 | โ |
| A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. | Notaras M et al. | โ | 2015 | โ |
| Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population. | Otsuka I et al. | โ | 2015 | โ |
| Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis. | Yao J et al. | โ | 2015 | โ |
| Association between variants of zinc finger genes and psychiatric disorders: systematic review and meta-analysis. | Sun Y et al. | โ | 2015 | โ |
| Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk. | Huentelman MJ et al. | โ | 2015 | โ |
| Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis. | Hass J et al. | โ | 2015 | โ |
| Association Study of CHRNA7 Promoter Variants with Sensory and Sensorimotor Gating in Schizophrenia Patients and Healthy Controls: A Danish Case-Control Study. | Bertelsen B et al. | โ | 2015 | โ |
| Association study of H2AFZ with schizophrenia in a Japanese case-control sample. | Jitoku D et al. | โ | 2015 | โ |
| Association study of VEGFA polymorphisms with schizophrenia in Han Chinese population. | Gao K et al. | โ | 2015 | โ |
| Beta-catenin in schizophrenia: Possibly deleterious novel mutation. | Levchenko A et al. | โ | 2015 | โ |
| Brain-specific epigenetic markers of schizophrenia. | Wockner LF et al. | โ | 2015 | โ |
| Cerebral Inefficient Activation in Schizophrenia Patients and Their Unaffected Parents during the N-Back Working Memory Task: A Family fMRI Study. | Jiang S et al. | โ | 2015 | โ |
| Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia. | Maschietto M et al. | โ | 2015 | โ |
| Common variants in the MKL1 gene confer risk of schizophrenia. | Luo XJ et al. | โ | 2015 | โ |
| Comorbid substance use disorders in schizophrenia: a latent class approach. | Kerner B | โ | 2015 | โ |
| CX3CR1 is dysregulated in blood and brain from schizophrenia patients. | Bergon A et al. | โ | 2015 | โ |
| Dendritic spine alterations in schizophrenia. | Moyer CE et al. | โ | 2015 | โ |
| Do nuclear-encoded core subunits of mitochondrial complex I confer genetic susceptibility to schizophrenia in Han Chinese populations? | Li X et al. | โ | 2015 | โ |
| Dopamine D1 receptor (DRD1) 5' region haplotypes significantly affect transcriptional activity in vitro. | Yao J et al. | โ | 2015 | โ |
| Effect of DISC1 polymorphisms on the long-term course of neurocognitive deficits in non-affective psychosis. | Vรกzquez-Bourgon J et al. | โ | 2015 | โ |
| Evaluating historical candidate genes for schizophrenia. | Farrell MS et al. | โ | 2015 | โ |
| Evaluating the association between CACNA1C rs1006737 and schizophrenia risk: A meta-analysis. | Jiang H et al. | โ | 2015 | โ |
| Evidence for a Shared Etiological Mechanism of Psychotic Symptoms and Obsessive-Compulsive Symptoms in Patients with Psychotic Disorders and Their Siblings. | Swets M et al. | โ | 2015 | โ |
| Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population. | Zhang Z et al. | โ | 2015 | โ |
| Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. | Hjelm BE et al. | โ | 2015 | โ |
| Experimental validation of candidate schizophrenia gene CALN1 as a target for microRNA-137. | Xia S et al. | โ | 2015 | โ |
| Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder. | Moises HW et al. | โ | 2015 | โ |
| GABAergic control of depression-related brain states. | Luscher B et al. | โ | 2015 | โ |
| Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls. | Calabrรฒ M et al. | โ | 2015 | โ |
| Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation. | Neale BM et al. | โ | 2015 | โ |
| Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. | Gupta CN et al. | โ | 2015 | โ |
| Genetics in child and adolescent psychiatry: methodological advances and conceptual issues. | Hohmann S et al. | โ | 2015 | โ |
| Genetic studies of schizophrenia: an update. | Chen J et al. | โ | 2015 | โ |
| Genetic variants in long non-coding RNA MIAT contribute to risk of paranoid schizophrenia in a Chinese Han population. | Rao SQ et al. | โ | 2015 | โ |
| Genome-wide significant linkage of schizophrenia-related neuroanatomical trait to 12q24. | Sprooten E et al. | โ | 2015 | โ |
| Genomic and network patterns of schizophrenia genetic variation in human evolutionary accelerated regions. | Xu K et al. | โ | 2015 | โ |
| Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes. | Ohi K et al. | โ | 2015 | โ |
| Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility. | Kimura H et al. | โ | 2015 | โ |
| Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood. | van Eijk KR et al. | โ | 2015 | โ |
| Impaired motor performance in adolescents at familial high-risk for schizophrenia. | Manschreck TC et al. | โ | 2015 | โ |
| Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation. | Xu Y et al. | โ | 2015 | โ |
| Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naรฏve patients with first-episode psychosis. | Ota VK et al. | โ | 2015 | โ |
| Induced pluripotent stem cells for modeling neurological disorders. | Russo FB et al. | โ | 2015 | โ |
| Influence of NRGN rs12807809 polymorphism on symptom severity in individuals with schizophrenia in the Han population but not the Zhuang population of south China. | Su L et al. | โ | 2015 | โ |
| Innate immune response is differentially dysregulated between bipolar disease and schizophrenia. | de Baumont A et al. | โ | 2015 | โ |
| Integration of gene expression and GWAS results supports involvement of calcium signaling in Schizophrenia. | Hertzberg L et al. | โ | 2015 | โ |
| Interaction between parental psychosis and early motor development and the risk of schizophrenia in a general population birth cohort. | Keskinen E et al. | โ | 2015 | โ |
| Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. | Pouget JG et al. | โ | 2015 | โ |
| IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. | Kendler KS et al. | โ | 2015 | โ |
| Laterality and mental disorders in the postgenomic age--A closer look at schizophrenia and language lateralization. | Ocklenburg S et al. | โ | 2015 | โ |
| Mechanisms of Long Non-coding RNAs in Mammalian Nervous System Development, Plasticity, Disease, and Evolution. | Briggs JA et al. | โ | 2015 | โ |
| Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms. | Cai L et al. | โ | 2015 | โ |
| Meta-analysis of data from the Psychiatric Genomics Consortium and additional samples supports association of CACNA1C with risk for schizophrenia. | Takahashi S et al. | โ | 2015 | โ |
| Mutation burden of rare variants in schizophrenia candidate genes. | Girard SL et al. | โ | 2015 | โ |
| NERI: network-medicine based integrative approach for disease gene prioritization by relative importance. | Simรตes SN et al. | โ | 2015 | โ |
| Network-Based Analysis of Schizophrenia Genome-Wide Association Data to Detect the Joint Functional Association Signals. | Chang S et al. | โ | 2015 | โ |
| [Neurobiology of schizophrenia: new findings from the structure to the molecules]. | Schmitt A et al. | โ | 2015 | โ |
| Neurocognitive functioning in parents of schizophrenia patients: Attentional and executive performance vary with genetic loading. | Schulze-Rauschenbach S et al. | โ | 2015 | โ |
| New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. | Lee SH et al. | โ | 2015 | โ |
| No Evidence for Enrichment in Schizophrenia for Common Allelic Associations at Imprinted Loci. | Escott-Price V et al. | โ | 2015 | โ |
| Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions. | Liu CH et al. | โ | 2015 | โ |
| Polygenic risk scores in imaging genetics: Usefulness and applications. | Dima D et al. | โ | 2015 | โ |
| Polygenic Scores in Epidemiology: Risk Prediction, Etiology, and Clinical Utility. | Maher BS | โ | 2015 | โ |
| Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains. | Saia-Cereda VM et al. | โ | 2015 | โ |
| Raising attention to attention deficit hyperactivity disorder in schizophrenia. | Pallanti S et al. | โ | 2015 | โ |
| Recent genetic findings in schizophrenia and their therapeutic relevance. | Harrison PJ | โ | 2015 | โ |
| Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. | Toulopoulou T et al. | โ | 2015 | โ |
| Refinement of schizophrenia GWAS loci using methylome-wide association data. | Kumar G et al. | โ | 2015 | โ |
| Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility. | Suรกrez-Rama JJ et al. | โ | 2015 | โ |
| RNA Sequencing in Schizophrenia. | Li X et al. | โ | 2015 | โ |
| Role of Hybrid Brain Imaging in Neuropsychiatric Disorders. | Burhan AM et al. | โ | 2015 | โ |
| Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. | Nasyrova RF et al. | โ | 2015 | โ |
| Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. | Samsom JN et al. | โ | 2015 | โ |
| Schizophrenia: a tale of two critical periods for prefrontal cortical development. | Selemon LD et al. | โ | 2015 | โ |
| Schizophrenia in the spectrum of gene-stress interactions: the FKBP5 example. | Daskalakis NP et al. | โ | 2015 | โ |
| Sleep and plasticity in schizophrenia. | Sprecher KE et al. | โ | 2015 | โ |
| Sleep in Schizophrenia: Pathology and Treatment. | Benson KL | โ | 2015 | โ |
| Systematic Integration of Brain eQTL and GWAS Identifies ZNF323 as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function. | Luo XJ et al. | โ | 2015 | โ |
| The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses. | Euesden J et al. | โ | 2015 | โ |
| Visualization analysis of author collaborations in schizophrenia research. | Wu Y et al. | โ | 2015 | โ |
| ZNF804A rs1344706 is associated with cortical thickness, surface area, and cortical volume of the unmedicated first episode schizophrenia and healthy controls. | Wei Q et al. | โ | 2015 | โ |
| Changes in gene expression and methylation in the blood of patients with first-episode psychosis. | Ota VK et al. | โ | 2014 | โ |
| Common variants at 1p36 are associated with superior frontal gyrus volume. | Hashimoto R et al. | โ | 2014 | โ |
| Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice. | Arime Y et al. | โ | 2014 | โ |
| Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders. | Schadt EE et al. | โ | 2014 | โ |
| Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes. | Guipponi M et al. | โ | 2014 | โ |
| [Genes ยซ for ยป schizophrenia]. | Jordan B | โ | 2014 | โ |
| Genetic liability for schizophrenia predicts risk of immune disorders. | Stringer S et al. | โ | 2014 | โ |
| Genome-wide methylation profiling of schizophrenia. | Rukova B et al. | โ | 2014 | โ |
| Opposite risk patterns for autism and schizophrenia are associated with normal variation in birth size: phenotypic support for hypothesized diametric gene-dosage effects. | Byars SG et al. | โ | 2014 | โ |
| Promoter variant rs2301228 on the neural cell adhesion molecule 1 gene confers risk of schizophrenia in Han Chinese. | Zhang W et al. | โ | 2014 | โ |
| Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders. | Xing J et al. | โ | 2014 | โ |
| [Role of bioinformatics in research and development of antipsychotic agents]. | Kuwahara Y et al. | โ | 2014 | โ |
| Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. | Crabtree GW et al. | โ | 2014 | โ |
| The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis. | Liu L et al. | โ | 2014 | โ |
| Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior. | Hussaini SM et al. | โ | 2014 | โ |